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In this dissertation, efforts were dedicated to the study of alkaloids in traditional 
Chinese medicines (TCMs). Various techniques of separation and determination 
of natural alkaloids in Chinese herbs have been developed and the metabolic 
profiling of alkaloid in rat model has been investigated. 
This dissertation is broadly divided into two parts: the first part (chapter 2 and 
chapter 3) focused on the separation and determination of toxic pyrrolizidine 
alkaloids (PAs) in Chinese herbal medicine, called Tussilago farfara (Kuan 
Donghua), and the second part (chapter 4) focused on the metabonomics studies 
of a commonly used TCM, named berberine, in rat model. 
In chapter 1, TCM was briefly reviewed from various aspects, including the 
background, separation and analysis and metabonomics of TCMs. 
Two new extraction techniques, microwave-assisted extraction (MAE) and 
pressurized hot water extraction (PHWE) were applied to the separation of toxic 
PAs from Tussilago farfara (Kuan Donghua) (Chapter 2). Conditions for MAE 
and PHWE were optimized. It was found that a binary mixture of MeOH:H2O (1:1) 
acidified using HCl to pH 2–3 was the optimal solvent for the extraction of the 
PAs in the plant materials. The results obtained from MAE and PHWE were 
compared against heating under reflux. LC with UV detection and electrospray 
ionization mass spectrometry (ESI-MS) in the positive mode were used for the 
determination and quantitation of PAs in the botanical extract. The proposed 
extraction methods with LC/MS allow for a rapid detection of both the major and 
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IX  
the minor PAs in T. farfara in the presence of co-eluting peaks. With LC/MS, the 
quantitative analysis of PAs in the extract was done using internal standard 
calibration and the precision was found to vary from 0.6% to 5.4% (n=6) on 
different days. The limits of detection (LODs) and limits of quantitation (LOQs) 
for MAE and PHWE were found to be 0.26 to 1.04 µg/g and1.32 to 5.29 µg/g, 
respectively. The method precision of MAE and PHWE were found to vary from 
3.7% to 10.4% on different days. The results showed that extraction efficiencies 
for major and minor PAs extracted using MAE and PHWE were comparable to 
that by heating under reflux. Our results also showed that significant ion 
suppression was not observed in the LC/MS analysis. 
In chapter 3, a simple and efficient non-aqueous capillary electrophoresis (NACE) 
method was established for the determination of toxic PAs in Tussilago farfara 
(Kuan Donghua) firstly. Influences from the background electrolyte (BGE) and 
separation voltage were investigated. Then two online preconcentration methods 
for NACE, named large volume sample stacking (LVSS) and field-amplified 
sample stacking (FASS), were investigated. The stacking conditions, such as the 
length of sample zone in LVSS, choice of organic solvent plug, organic solvent 
plug length, sample injection voltage and injection time in FASS, were optimized. 
Under the optimized conditions, the FASS could provide 18 to 89–fold sensitivity 
enhancements with satisfactory reproducibility, while the LVSS could only 
provide 5 to 7-fold. 
In chapter 4, methods using gas chromatography/mass spectrometry (GC/MS), 
Summary 
X  
liquid chromatography/mass spectrometry (LC/MS) and 1H NMR with pattern 
recognition tools such as principle components analysis (PCA) were used to study 
the metabolic profiles of rats after the administration of berberine. From the 
normalized peak areas obtained from GC/MS analysis of liver extracts and 
LC/MS analysis of urine samples and peak heights from 1H NMR analysis of 
urine samples, statistical analyses were used in the identification of potential 
biomarkers. The results from non-targeted 1H NMR data processing had proved 
the reliability and accuracy of targeted LC/MS data processing. The proposed 
approach provided a more comprehensive picture of the metabolic changes after 
administration of berberine in rat model. The multiple parametric approach 
together with pattern recognition tools is a useful platform to study metabolic 
profiles after ingestion of botanicals and medicinal plants. 
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Chapter 1 Introduction 
1.1 Traditional Chinese Medicine (TCM) 
Traditional Chinese medicines (TCMs) which have been used to treat as well as 
prevent various diseases for more than 2000 years in China are getting more and 
more popular nowadays in the whole world. They have been modified to some 
extent in other Asian countries, such as Korea and Japan and have attracted 
significant attention in European, Australia and North American countries during 
the last two decades [1]. Since Chinese medicine is generally extracted from 
natural products without artificial additives which creates mild healing effects and 
incurs fewer side effects, it has been considered as an important complementary 
and alternative medicine in Western countries. At the same time Chinese herbs 
have always been the most important resources for screening lead compounds. 
Chinese Pharmacopoeia has recorded more than 500 examples of crude drugs 
from plants and 400 TCMs that are widely used all over the world [2, 3]. These 
drugs are multi-component systems, containing usually hundreds of chemically 
different constituents which can act in a synergistic manner within the human 
body, and can provide unique therapeutic properties with minimal or no 
undesirable side-effects [4]. However, only a few, if not one, compounds are 
responsible for the beneficial and/or hazardous effects [5]. For example, as the 
most famous and commonly used Chinese herb in Chinese history, Ginseng, the 
root and rhizome of Panax spp., has multifold bioactivities including 
antimitogenic effect, improving impaired memory and inhibition of tumor cell 
growth. The pharmacological properties of Ginseng are generally attributed to its 
triterpene glycosides, called ginsenosides [5]. The dried root of Salvia miltiorrhiza 
Bunge (Chinese name ‘Danshen’) is another Chinese herb of the most well-known 
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traditional Chinese medicines. It is widely used to treat coronary heart diseases, 
cerebrovascular diseases, bone loss, hepatitis, hepatocirrhosis and chronic renal 
failure, dysmenorrheal and neurasthenic insomnia. Phenolic acids are the water 
soluble active constituents of Danshen [5]. 
However, due to the complicate constitutions of herbal medicines, besides the 
therapeutic effects, TCMs show toxic effects also. For example, Tussilago farfara 
(Kuan Donghua) is commonly used for the relief of coughs and as an expectorant, 
blood pressure raiser, platelet activating factor and anti-inflammatory agent [6]. It 
also can be used for the treatment of asthma, silicosis, pulmonary tuberculosis, 
obesity, type 2 diabetes, and hepatitis [7–12]. However, the toxic pyrrolizidine 
alkaloids included in Tussilago farfara are hepatotoxic, lung carcinogenesis, 
neurotoxic and cytotoxic. Lilu, the roots and rhizomes of several Veratrum species, 
has been used to treat aphasia arising from apoplexy, wind-type dysentery, 
jaundice, scabies and chronic malaria for centuries in China. Nevertheless, 
Veratrum nigrum L. is a very poisonous plant. The steroidal alkaloids isolated 
from this plant were reported to exert teratogenic effects in several laboratory 
animals. Perharic et al. [13] reported the toxicological problems resulting from 
exposure to TCMs in 1994.  
Until recently, there are still a lot of components unknown in TCMs, just like a 
“black-box” system. What's more, the constituents in them are influenced by three 
principal factors: heredity (genetic composition), ontogeny (stage of development) 
and environment (e. g. climate, associated flora, soil and method of cultivation). 
Therefore, the action mechanisms of TCMs are often difficult to be clearly 
understood. As a result, developing effective techniques for isolation or separation 
and analysis of effective or toxic components in TCMs is a very important subject 
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in order to ensure their reliability and repeatability of pharmacological and clinical 
research. 
1.2 Separation and Analysis of TCM 
1.2.1 Separation Technology 
Sample preparation is the crucial first step in the chromatographic analysis of 
TCMs, because it is necessary to extract the desired chemical components from 
the herbal material for further separation and characterization. Thus, the 
development of novel sample-preparation techniques with significant advantages 
over conventional methods (e.g. reduction in organic solvent consumption and in 
sample degradation, elimination of additional sample clean-up and concentration 
steps before chromatographic analysis, improvement in extraction efficiency, 
selectivity, and/or kinetics, ease of automation, etc.) for the extraction and 
analysis of medicinal plants plays an important role in the overall effort of 
ensuring and providing high quality herbal products to consumers worldwide. 
Herein, the recent sample-preparation techniques including headspace solid-phase 
microextraction (HS-SPME), headspace liquid-phase microextraction (HS-LPME), 
supercritical-fluid extraction (SFE), ultrasonic extraction (UE), 
microwave-assisted extraction (MAE), pressurized-liquid extraction (PLE) and 
microwave distillation (MD) will be introduced. 
1.2.1.1 Headspace Extraction Techniques 
The medicinal properties of TCMs can be partly related to the presence of volatile 
constituents (e.g. essential oils) in the plant matrix, and GC–MS and GC–FID are 
frequently used for determination of these volatile components. Because the 
sample to be injected should be free from non-volatile components, a fractionation 
step is necessary before GC analysis. The disadvantages of commonly used 
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sample preparation techniques, such as distillation and liquid solvent extraction, 
are that they usually require large amounts of organic solvents and manpower. 
These methods also tend to be destructive in nature and significant artifact 
formation can occur due to the sample decomposition at high temperatures [14]. 
Recently, the two techniques of HS-SPME and HS-LPME have been developed 
for the extraction of volatile constituents from TCMs. 
1.2.1.1.1 Headspace Solid-phase Microextraction (HS-SPME) 
In 1990, Arthur and Pawliszyn [15] introduced a completely solvent-less method, 
named solid-phase microextraction (SPME), in which a fused silica fiber coated 
with a stationary phase is exposed to the sample or its headspace and the target 
analytes partition from the sample matrix to the fiber coating [16]. After 
extracting for a set period of time, the fiber is transferred to the heated injection 
port for GC or GC–MS analysis. The method has been applied widely in recent 
years to the determination of the volatile chemical components of plants and 
flowers [17–22]. Subsequently, HS-SPME was successfully applied to the 
analyses of volatile components in TCMs, such as Schisandra chinensis Bail, 
Chinese arborvitae, Angelico pubescens, and Angelico sinensis [23-26]. It was 
proved that the reproducible and rapid determination of volatile compounds in 
TCMs could be achieved when HS-SPME was used coupling with GC–MS, with 
the advantages of eliminating the extraction or fractionation step and reducing 
artifact formation. HS-SPME was also developed as a quality assessment tool for 
Flos Chrysanthemi Indici from different growing areas [27]. In 2004, HS-SPME 
was developed for the analysis of 35 volatile constituents in Rhioxma Curcumae 
Aeruginosae [28], and 27 compounds in the TCM prescription of 
Xiao-Cheng-Qi-Tang [29]. In 2006, Guo and Huang [30] analyzed Atractylodes 
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macrocephala (baizhu) and Atractylodes lancea (cangzhu) with HS-SPME and 
found 23 common components. Qi et al. analyzed the volatile compounds from 
Curcuma wenyujin and Houttuynia cotdata by using HS-SPME–GC–MS [31, 32]. 
Compared to distillation, HS-SPME was a simple, rapid, and solvent-free sample 
extraction and concentration technique which has a strong potential for monitoring 
the quality of TCMs. 
1.2.1.1.2 Headspace Liquid-phase Microextraction (HS-LPME) 
LPME was firstly introduced by Jeannot and Cantwell [33, 34] and He and Lee 
[35]. It is performed by suspending 1µL drop of organic solvent on the tip of 
either a Teflon rod or the needle tip of a microsyringe immersed in the stirred 
aqueous sample. Then the microdrop was injected to GC-MS. The LPME 
technique has been successfully applied to environmental analysis and drug 
analysis [36–40]. HS-LPME was firstly introduced by Theis et al. for volatile 
organic compounds in an aqueous matrix in 2001[41]. Cao and Qi found similar 
results by HS-LPME and HS-SPME for the analysis of 66 volatile compounds 
from a common TCM, C. wenyujin [42]. 
HS-SPME and HS-LPME have similar capabilities in terms of precision and 
speed of analysis and are very suitable for quality assessment of TCMs. However, 
the latter is prior to the former considering the choice of solvents is wider than the 
limited number of stationary phases for SPME and the cost of the few microliters 
of solvent is negligible compared to the cost of commercially available SPME 
fibers. 
1.2.1.2 Supercritical-fluid Extraction (SFE) 
Supercritical-fluid extraction has been used for many years for the extraction of 
volatile components, e.g. essential oils and aroma compounds, from plant 
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materials, on a laboratory and industrial scale [43, 44]. As far as SFE is concerned, 
the extraction time is short, the use of hazardous solvents can be reduced. It is also 
very convenient to couple with GC, LC and supercritical-fluid chromatography. 
The application of SFE to the extraction of active compounds from medicinal 
plants has attracted a lot of attention due to the avoiding of degradation caused by 
lengthy exposure to elevated temperatures and atmospheric oxygen. 
Supercritical carbon dioxide extraction has been successfully applied to extract the 
essential oil for GC–MS from Aloe vera [45], Polygonum cuspidatum [46], radix 
Angelicae dahuricae [47], ginger [48], and Cinnamomum cassia presl [49]. SFE 
with methanol-modified supercritical carbon dioxide, followed by LC has been 
reported for the analysis of sinomenine from Sinomenium acutum [50], berberine 
from rhizome of Coptis chinensis Franch [51], triterpenoids in fruiting bodies of 
Ganoderma lucidum [52], and saponins from Ginseng [53]. The application of 
SFE coupling with LC and LC×LC to the analysis of G. lucidum has also been 
reported [54, 55]. 
Recently, the coupling of SFE with high-speed counter-current chromatography 
(HSCCC) has been used for the extraction and isolation of flavonoids [56, 57], 
aurentiamide acetate from Patrinia villosa Juss [58] and psoralen and isopsoralen 
from Fructus Psoraleae [59]. Today, many active compounds are obtained by 
using SFE–HSCCC technique. 
1.2.1.3 Ultrasonic Extraction (UE) 
The first application of ultrasonic energy to the extraction of medicinal 
compounds from plant materials can be tracked back to 1950s. The mechanisms 
of the useful ultrasonically assisted extraction could be described into two 
directions [60]. Firstly, some plant cells occur in the form of glands (external or 
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internal) filled with essential oil. A characteristic of external glands is that their 
skin is very thin and can be easily destroyed by sonication, thus facilitating release 
of essential oil contents into the extraction solvent. The other is ultrasound can 
also facilitate the swelling and hydration of plant materials to cause enlargement 
of the pores of the cell wall. Better swelling will improve the rate of mass transfer 
and, sometimes, break the cell walls, thus resulting in increased extraction 
efficiency and/or reduced extraction time. 
As a novel approach to extraction and sample preparation for medicinal herbs, 
Huie et al. reported the application of ultrasound to assist the surfactant-mediated 
extraction of ginsenosides from American ginseng [61]. In ultrasonically assisted 
extraction the aqueous surfactant solution containing 10% Triton X-100 as the 
extraction solvent can be used to fasten the extraction kinetics and obtain higher 
recovery compared to methanol and water. 
1.2.1.4 Microwave-assisted Extraction (MAE) 
The use of microwave energy for heating the solution (microwave-assisted 
extraction, MAE) results in significant reductions in both the extraction time and 
the consumption of organic solvents compared with conventional liquid–solid 
extraction methods, such as soxhlet extraction [62]. This is because the 
microwaves heat the solvent or solvent mixture directly, thus improving the 
efficiency of heating. Solvent composition, solvent volume, extraction 
temperature, and matrix characteristics are the most important parameters that can 
affect the MAE efficiency. Until recently, MAE has been widely applied for the 
extraction of flavonoids from Acanthopanax senticosus Harms, Mahonia bealei 
(Foft.) leaves, and Chrysanthemum morifolium (Ramat.) petals, for rutin and 
quercetin from Flos Sophorae, for six ginsenosides from ginseng root and for the 
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water-soluble bioactive constituents from the traditional Chinese medicinal 
preparation Tongmaichongji [63–68]. In 2005, Liu et al. reported the use of 
high-pressure MAE for the extraction of flavonoids and saponins from A. 
senticosus leaves [69]. Most recently, MAE has been combined with HS-SPME or 
HS-LPME for the quantitative analysis of volatile active components in TCMs 
[70–72]. This technique provided a simple, rapid and solvent-free tool for the 
quantitative analysis of active compounds in TCMs. 
MAE has also been successfully applied to the analysis of heavy metals in herbal 
products which play an important role in the therapeutic effects, despite their 
reported toxicity. The determination of metals, such mercury, arsenic and lead in 
traditional Chinese medicines have been reported [73-76]. 
1.2.1.5 Pressurized-liquid Extraction (PLE) 
Pressurized-liquid extraction (PLE) emerged in the mid-1990s. However, the first 
comprehensive study on the feasibility/usefulness of applying PLE in medicinal 
herb analysis was carried out until 1999 by Benthin et al. [77]. The sample was 
extracted with water or organic solvent or the mixture of both in a stainless-steel 
cell under elevated temperature and pressure. Normally, the temperature ranges up 
to 350oC and the pressure is kept as high as enough to keep the extraction solvents 
in a liquid state. Under these conditions, the solubility of the analytes and the mass 
transfer are increased, and the viscosity and the surface tension of the solvents are 
decreased. These can improve the contact of the analytes with the solvent and thus 
enhance the extraction [78]. Recently, Li’s group has coupled PLE with capillary 
electrophoresis (CE), GC and HPLC for the determination of 5 anthraquinones 
from Rhubarb [79], 11 sesquiterpenes from Ezhu, which is derived from three 
species of Curcuma [80, 81], 11 major triterpene saponins from Panax 
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notoginseng [82–85], 43 nucleosides, bases and their analogues in natural and 
cultured Cordyceps [86], Z-ligustilide, Z-butylidenephthalide, and ferulic acid 
from Angelica sinensis [87], saponins and fatty acids from Suanzaoren [88], and 
alkaloids and limonoids from Cortex Dictamni [89]. Ong and co-workers [90] 
found that PLE is superior to conventional extraction methods such as ultrasonic 
and Soxhlet extraction for the extraction of berberine and aristolochic acids in 
medicinal plants. Later he reported the use of PLE coupled with CE for the 
determination of glycyrrhizin in Radix glycyrrhizae or liquorice [91]. 
Since the polarity of water decreases markedly when liquid water is under 
elevated temperature (ranging from 100 to 374 ◦C) and elevated pressure. It can be 
used for the pressurized hot water extraction (PHWE) of a wide range of analytes. 
Fernandez- Perez et al. reported the application of PHWE to the extraction of 
essential oils in plant materials [92]. Zhang et al. reported the use of PHWE for 
the analysis of α-asarone in the dry rhizome of the common TCM Acorus 
Tatarinowii Schott [93], Z-ligustilide and E-ligustilide, from Ligusticum 
chuanxiong and A. sinensis [94, 95], and volatile active compounds such as 
Fructus amomi [96,97]. Ong et al. investigated the application of PHWE for 
extraction of berberine in coptidis rhizoma, glycyrrhizin in radix 
glycyrrhizae/liquorice and baicalein in scutellariae radix [98] and compared PLE 
with PHWE for the extraction of thermally labile components such as tanshinone I 
and IIA in Salvia miltiorrhiza [99]. The application of PHWE for bioactive or 
marker compounds in botanicals and medicinal plant materials was reviewed 
[100]. 
1.2.1.6 Microwave Distillation (MD) 
Microwave distillation (MD), which is a combination of microwave heating and 
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dry distillation at atmospheric pressure was invented by Chemat et al. in 2003 
[101]. MD involves placing plant material in a microwave reactor, without any 
added solvent or water. The internal heating of the water within the plant material 
distends the plant cells and leads to rupture of the glands and oleiferous 
receptacles. This frees essential oils which are evaporated by the water of the plant 
material. A cooling system outside the microwave oven condenses the distillate. 
The excess of water was refluxed to the extraction vessel in order to restore the 
water to the plant material [102]. Lucchesi et al. reported the application of MD to 
extract essential oils from aerial parts of three aromatic herbs: basil (Ocimum 
basilicum L.), garden mint (Mentha crispa L.) and thyme (Thymus vulgaris L.) 
[103]. Recently, Wang et al. applied the MD technique for the extraction of 
essential oils from Cuminum cyminum L. and Zanthoxylum bungeanum Maxim 
[104]. MD combined with headspace techniques, such as HS-SPME and 
HS-LPME, had been successfully applied for the extraction and concentration of 
volatile compounds from TCMs [105–107] using a short analysis time and no 
solvent. 
1.2.2 Analysis of TCMs by Chromatographic Techniques 
As mentioned above, TCMs are complex mixtures containing up to hundreds or 
even thousands of different components with significant difference in the content 
and physical and chemical properties. However, only a few compounds are 
responsible for the pharmaceutical and/or toxic effects. The large numbers of 
other components in the TCM make the screening and analysis of the bioactive 
components extremely difficult. Consequently, many methods, such as GC/MS, 
HPLC/MS, CE, etc., have been proposed in recent years. In addition, hyphenated 
instruments, such as GC/MS, HPLC/MS, etc., combining a chromatographic 
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separation system on-line with a spectroscopic detector in order to obtain 
structural information on the analytes, have great potential in analyzing herbal 
medicines. These instruments generate huge amounts of data. The 
chromatographic profile of a complex mixture such as TCM extracts almost 
always contained overlapped peaks. These overlapped peaks hinder the 
identification of chemical components, as pure spectra of the corresponding 
components cannot be obtained. The chemometric techniques are required to 
retrieve the information these data contained. 
1.2.2.1 Analysis of TCMs by GC 
As we all know that a lot of therapeutic components in TCMs are volatile. Hence, 
GC is a very important and useful technique for the analysis of these volatile 
compounds in the past decades [108-114] due to its advantages: (1) both the 
characteristic compounds of the particular plants and impurities can be detected, 
(2) with the development of the extraction of volatile oil techniques, the 
pharmacologically active components can be possibly identified using GC/MS 
analysis, (3) the high sensitivity of GC and/or GC/MS ensures the detection for 
almost all the volatile chemical compounds, (4) many volatile compounds can be 
separated simultaneously within comparatively short times due to the high 
selectivity of capillary columns. Until recently, MS is the most sensitive and 
selective method for molecular analysis which can yield information on the 
molecular weight as well as the structure of the molecule. The coupling of GC 
with MS provides the advantages of both chromatography as a separation method 
and MS as an identification method. For GC/MS, electron impact (EI) is primarily 
configured to select positive ions from the analytes, while electron capture 
ionization is usually configured for negative ions. GC/MS has been the first 
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successful online combination of chromatography with MS, and has been widely 
applied for the analysis of essential oil in herbal medicines [115– 127]. With the 
help of GC/MS, not only a separated chromatographic profile of the essential oil 
of the herbal medicine could be obtained but also the information related to its 
most qualitative and relative quantitative composition could be produced 
[128–134]. For example, the combination of PHWE, HS-SPME and GC/MS was 
successfully applied for the determination of three volatile compounds of 
eucalyptol, camphor, and borneol in Chrysanthemum flowers [129] and 
Z-ligustilide and E-ligustilide [130]. HS-SPME followed by GC/MS was also 
applied to determine asarone in rabbit plasma at different time points after oral 
adminstration of the essential oil from A. tatarinowii [131]. 
1.2.2.2 Analysis of TCMs by LC 
With the advantages of high reproducibility, good linear range, ease of automation 
and ability to analyze the number of constituents in botanicals and herbal 
preparation, liquid chromatography (LC) with an isocratic/gradient elution 
remains to be the primary method of choice in the analysis of TCMs. For LC, the 
reversed octadecyl silica (C18) is one of the most commonly used columns. Ong 
reported that columns with smaller inner diameter, such as 1.0 or 2.1 mm i.d. were 
well suited to the analysis of components present in botanicals. Most important of 
all, methods using columns with smaller inner diameter and the right mobile phase 
can be readily adopted to mass spectrometry [135]. Applications of LC method to 
medicinal plants and Chinese traditional medicines are outlined [136]. Methods 
using gradient elution HPLC coupling with reversed phase columns had been 
applied for the analysis of multiple constituents present in medicinal plants and 
herbal preparations [137–139]. 
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Until recently, the most common mode of detection remains to be ultraviolet (UV) 
detection. Gradient elution HPLC with UV detection, using a C18 reversed phase 
column had been successfully applied to profile components present in C. rhizoma, 
Radix aristolochiae, ginseng, R. glycyrrhizae (liquorice), S. radix, R. codonopsis 
pilosula and S. miltiorrhiza [140-144]. And due to the complexity of the matrix, 
co-eluting peaks were often observed in the chromatograms obtained from the 
analysis of marker compounds in herbal preparations with two or more medicinal 
plants [145]. The co-eluting peaks might be reduced by additional sample 
preparation steps, such as liquid-liquid partitioning, solid phase extraction, 
preparative LC and TLC fractionation. 
In recent years, there is a dramatical increase in the study of LC/MS for analysis 
of TCMs due to the low sensitivity and specificity of UV detection. For 
HPLC/MS, the most common mode of sample ionization includes ESI and 
chemical API. 
The LC-ESI/MS technique has been used for the analysis of 17 compounds and 
their plant derivations of Xue-Fu-Zhu-Yu decoction, consisting of six crude drugs 
[146], for the identification and quantification of paeonol [147], paeoniflorin [148], 
oxysophocarpine and its active metabolite sophocarpine [149] in rat plasma, for 
the simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone 
IIA and cryptotanshinone, the active components of Salvia miltiorrhiza in rat 
plasma [150], and for determination of oxymatrine and matrine in beagle dog 
plasma [151]. It has also been successfully applied for the analysis of chemical 
and metabolic components in TCM combined prescription containing Radix 
Salvia miltiorrhiza, for quantification of pinane monoterpene glycosides in Cortex 
Moutan [152] and Radix Panax notoginseng [153] and the determination of 
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adonifoline, a retronecine-type hepatotoxic pyrrolizidine alkaloid in Senecio 
scandens Buch.–Ham. ex D. Don [154]. 
The chemical API source has been employed to tackle the matrix interference in 
analyzing Chinese medicinal materials and to minimize the associated matrix 
effects that were commonly encountered with other ionization modes. Moreover, 
the method allowed direct interface to conventional HPLC systems [155]. The 
HPLC/MS method using a chemical API source has been applied for separation 
and identification of four major bioactive sesquiterpene alkaloids (Wilfortrine, 
wilfordine, wilforgine and wilforine) in Tripterygium wilfordii Hook. F. [156], for 
the biological fingerprinting analysis of bioactive components in a TCM 
prescription, Longdan Xiegan Decoction (LXD) [157], and for the differentiation 
of three ginseng species: Panax quinquefolium (American ginseng), P. ginseng 
(Chinese ginseng) and P. notoginseng (sanqi) species [158]. 
Recently, the technique of Ultra Performance-LC (UPLC) has been developed. 
With UPLC, the time and solvent consumption can be decreased. This new 
technique combined with MS has been used for chemical profiling of Epimedium 
brevicornum Maxim., as well as endogenous metabolite profiles of rats pre- and 
post-hydrocortisone interfered and treated with this herbal medicine [159] and for 
analysis of many other TCMs [160-168]. 
One of the challenges for the analytical methods developed was to study the 
effects of batch-to-batch variations in the medicinal plants [135, 141, 169-170]. 
Ong et al. investigated the batch-to-batch variations of the plant materials. The 
PLE-LC-UV method was used to assay the content of baicalein in S. radix from 
four different sources [170]. They concluded that the assayed of markers or active 
compounds together with chemical fingerprinting, using HPLC, would be able to 
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provide further information about the quality of the botanicals and herbal 
preparations. 
1.2.2.3 Analysis of TCMs by Capillary Electrophoresis (CE) 
Capillary Electrophoresis (CE) was introduced in the early 1980s as a powerful 
analytical and separation technique [230]. Until recently, several modes of CE are 
available: (i) capillary zone electrophoresis (CZE), (ii) micellar electrokinetic 
chromatography (MEKC), (iii) capillary gel electrophoresis (CGE), (iv) capillary 
isoelectric focusing (CIEF), (v) capillary isotachophoresis (CITP), (vi) capillary 
electrochromatography (CEC) and (vii) non-aqueous capillary electrophoresis 
(NACE). The simplest and most versatile CE mode is CZE, in which the 
separation is based on the differences in the charge-to-mass ratio and analytes 
migrate into discrete zones at different velocities in the electrophoretic buffer in 
the capillary. For MEKC, another most commonly used CE method, the main 
separation mechanism is based on solute partitioning between the micellar phase 
and the solution phase. The pH of running buffer, ionic strength, applied voltage, 
concentration and type of micelle added and additives such as organic, ionic 
liquids and nanostructures, and so on, are important parameters that can affect the 
separation in CZE and MEKC. Compared with LC, CE shows several advantages: 
(1) high separation efficiency, (2) specific selectively, (3) reduction of organic 
solvent consumption, (4) small sample volume, (5) short analysis time, and (6) 
low cost of accessories, such as the use of capillaries instead of more expensive 
LC columns. As a result, CE has been proved to be a powerful alternative to LC in 
the analysis of natural medicines or natural products in complex matrix. 
Until recently, CE has been widely used for the analysis of TCMs. It has been 
applied to determine the amount of catechin and others in tea composition, 
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phenolic acids in coffee samples and flavonoids and alkaloids in plant materials 
[171-172], to differentiate between medicinal plant, such as S. radix from 
Astragali radix [173], to determine aristolochic acids in R. aristolochiae, 
strychnine in Strychnos nux-vomica, berberine in Rhizoma coptidis and 
glycyrrhizin in R. glycyrrhizae [174-176], to analyse quaternary alkaloids of 
Coptis chinensis [177], to estimate Synephrine level in Evodia fruit and eight 
samples of TCM [178], to quantitate apigenin in Chamomilla recutita L. 
Rauschert [179] and to determine jasminoidin, paeoniflorin and paeonol in jiawei 
xiaoyao pills [180], bufadienolides in toad venom and their Chinese medicinal 
preparations [181] as well as synephrine, hesperidin, naringenin and naringin in 
Fructus anrantii Immaturus and Fructus aurantii [182]. CZE has also been widely 
used to separate and determine four phenylpropanoid glycosides from T. 
chamaedrys [183], to identify and determine ordycepin (3’-deoxyadenosine) in 
Cordyceps kyushuensis Kob [184], to determine five active components in the 
TCM preparation, Huangdan Yinchen Keli [185], rhein, baicalin and berberine in 
TCM preparations, Sanhuangpian, Niuhuangjiedu-pian and 
Huanglianshangqing-pian [186], quercetin, luteolin, kaempferol and isoquercitrin 
in stamen nelumbinis [187] and genistein, rutin, baicalin and gallic acid in 
Huaijiao pills [188]. 
Among the different modes of CE, MEKC is another commonly used method for 
the analysis of TCMs. Until recently, it has been widely applied to determine 
icariin, rhein, chrysophanol, physcion, glycyrrhetic acid and glycyrrhizic acid in 
traditional Chinese herbal preparations [189], to determine three bioactive 
compounds (andrographolide, deoxyandrographolide and neoandrographolide) in 
Andrographis paniculata [190], to analyze two TCM preparations, Chuanxinlian 
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and Xiaoyan Lidan tablets [191], to determine hesperidin, naringin, puerarin and 
daidzein in medicinal preparations [192-193], to analyze G. rhodantha, G. kitag, 
G. scabra, G. rigescens, and G. macrophylla in Gentiana samples from Tibetian 
medicines [194],to determine Gastrodin and tetramethylpyrazine in three TCM 
preparations, Zhennaoning jiaonang, Yangxue shengfa and Xiaoshuan zaizaowan 
[195], to identify and determine diterpenoid triepoxides in Tripterygium wilfordii 
Hook F. and its preparations [196] and determine syringin and chlorogenic acid in 
Acanthopanax senticosus from different parts [197]. In our group, we have 
developed a new MEKC system with organic modifier for the analysis of 
mutagenic pyrrolizidine alkaloids in TCMs [198]. 
NACE is a newly developed method as an alternative for the analysis of TCMs 
due to its specific characterics. In our group, the determination of five toxic 
alkaloids in aconitine root (Radix aconitini praeparata), seeds of Strychnos 
pierrian and TCM preparation Shen Jin Huo Luo Wan by NACE was reported for 
the first time [199]. Three aconitine alkaloids (hypoconitine, aconitine and 
mesaconitine) and other unknown compounds coexisting in the five TCM, 
Chuanwu, Caowu, Fuzi, Aconitum tanguticum Maxim. and Aconitum 
gymnandrum were completely separated by non-aqueous CE within 13 min [200]. 
Li et al. reported the use of NACE for the determination of fangchinoline and 
tetrandrine in Stephania tetrandra and Fengtongan capsule [201]. NACE has also 
been successfully applied for the separation and determination of palmatine and 
jatrorrhizine in Tinospora capillipes Gagn from different original areas [202]. 
It is clearly that CE has been proved to be a valuable tool for the analysis of 
TCMs. 
 
Chapter 1 Introduction 
18  
1.3 Metabonomics of TCMs 
As far as TCMs is concerned, the toxicity is another important research area. All 
the information mentioned above can only tell us the existence of certain 
components, for the toxicity study, metabonomics will be introduced. 
1.3.1 Metabonomics 
Metabonomics is defined as “the quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to pathophysiological 
stimuli or genetic modification” and aims at “the augmentation and 
complementation of the information provided by measuring the genetic and 
proteomic responses to xenobiotic exposure” [203]. 
Metabolite or metabolic profiling, the compositional analysis of low 
molecular-weight species in biological samples, has existed for at least 35 years 
already. Mass spectrometry (MS) coupled with some separation techniques such 
as gas chromatography (GC) has been used for resolution and detection of 
metabolites [204]. 
In other words, metabonomics encompasses “the comprehensive and simultaneous 
systematic profiling of metabolite levels and their systematic and temporal 
changes through such effects on diet, lifestyle, environment, genetics, and 
pharmaceuticals, both beneficial and adverse, in whole organisms. This is 
achieved by the study of biofluids and tissues with the data being interpreted using 
chemometrics techniques” [205]. 
Recently, with the success of genomics and proteomics, a novel field name 
metabolomics has been established. It is defined as the comprehensive 
identification and quantification of the set of metabolites synthesized by an 
organism, or metabolome [206-208]. Comparing metabolomics and 
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metabonomics, the former is concerned with the comprehensive metabolic 
profiling at some scale, while the latter primarily focused on the history of time 
dependent metabolic profiles in an integrated system. 
For toxicity studies, the metabolic profiling of biofluids in addition to tissue 
analysis can reveal the integrated physiological and not just tissue-specific 
behavior of an organism. And multiple or continuous sampling through time from 
the same individual is possible due to its minimally invasive character. 
In short, information on in vivo multiorgan functional integrity in real time can be 
obtained through metabonomics. Hence, it might provide the key to achieving a 
“systems biology” approach to toxicology: the combination of genomic, 
proteomic, and metabolic data from toxicological studies. 
1.3.2 Metabonomics Samples 
Biofluids or cell or tissue extracts are generally used for the metabonomics studies. 
These samples are easy to collect. The mammalian biofluids can provide an 
integrated view of the whole systems biology. Among the different kinds of 
biofluids, urine and plasma are the most commonly used samples. In addition, 
tissue biopsy samples and their lipid and aqueous extracts have been used for a lot 
of metabonomics studies. 
1.3.3 Metabonomics Analysis Technologies 
There are many analytical techniques that can be used for metabonomics studies, 
such as Nuclear Magnetic Resonance (NMR) spectroscopy , GC-MS, LC-MS, 
CE-MS, Fourier transform infrared (FTIR), and so on. Metabonomics make use of 
these instruments to detect the minute quantities of metabolites in the organisms. 
Here, we will focus on the main methods: NMR, GC-MS and LC-MS. 
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1.3.3.1 NMR Spectroscopy 
Historically, the definition of metabonomics has been NMR based. It arose from 
the application of NMR to study the metabolic composition of biofluids, cells, and 
tissues. As a nondestructive technique, NMR has been widely used in chemistry to 
provide detailed information on molecular structure, both for pure compounds and 
in complex mixtures [209]. It can also report on hundreds of compounds in a 
single measurement with minimal sample preparation. In NMR spectra, individual 
signals are dispersed according to the chemical environment of the source nuclei 
and are directly proportional to the amount of material present. So NMR spectra 
can provide abundant structural information and quantification basis. Therefore, 
NMR spectroscopic methods are useful tools for probing metabolite molecular 
dynamics and mobility as well as substance concentrations through the 
interpretation of NMR spin relaxation times and by the determination of 
molecular diffusion coefficients [210]. 
A typical 1H NMR spectrum of urine sample contains thousands of sharp peaks 
from predominantly low molecular weight metabolites. The large interfering water 
signal in NMR spectra of biofluids can be eliminated by use of appropriate 
standard NMR water suppression method. The most commonly used reference 
compound in aqueous media is the sodium salt of 3-trimethylsilylpropionic acid 
(TSP) with methylene groups deuterated to avoid giving rise to peaks in the 1H 
NMR spectrum. 
Until recently, NMR has been successfully used for metabonomics research 
[211-216]. For example, it has been used to compare metabonomics of differential 
hydrazine toxicity in the rat and mouse [211], study the differentiation of gender, 
diurnal variation and age in human urinary metabolic profiles [214], and so on. 
Chapter 1 Introduction 
21  
1.3.3.2 Mass Spectrometry 
Although NMR has its effectiveness, it suffers from two major drawbacks: poor 
sensitivity and resolution. While mass spectrometry coupling with 
chromatographic techniques such as GC or LC, can counteract these problems. A 
recently introduced ultra-performance liquid chromatography (UPLC)-MS has 
resulted in a highly sensitive and high resolution instrument that can also be used 
for metabonomics studies. Due to the much improved chromatographic resolution 
of UPLC, the typical problem of ion suppression for MS, which can impair the 
sensitivity to any particular chemical species, could be greatly reduced. 
Until recently, MS has been widely applied for metabonomics studies on plant 
extracts, model cell system extracts and mammalian cells. For plant metabolic 
studies by GC/MS, chemical derivatization has been used to ensure volatility and 
analytical reproducibility for most investigations. For metabonomics applications 
on biofluids such as urine, LC/MS with electrospray ionization is commonly used. 
Both the positive and negative ion chromatograms would be measured. In a full 
mass spectrum, each sampling point is three dimensional in nature, i.e., retention 
time, mass, and intensity. We can select any peaks we want, or cut out any mass 
peaks from interfering substances without affecting the integrity of the data set. 
Mass Spectrometry has been successfully applied to many metabonomics studies 
so far [217-222]. For instance, it has been used to study profiling of serum fatty 
acids from Type 2 diabetic patients [217], liver diseases [219], within-day 
reproducibility of human urine samples [221], and so on. 
In summary, NMR and MS are complementary methods. Normally, it is necessary 
to use both of them for full molecular characterization. MS can provide high 
sensitivity given the analytes can be ionized, while NMR spectroscopy can 
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distinguish isomers, obtain molecular conformation information and study 
molecular dynamics and compartmentation. There are also many studies reporting 
the use of a combination of both MS and NMR or more analytical techniques 
[223-227]. In our group, metabonomics of human urine after ingestion of green 
tea was investigated through the combination of GC/MS, LC/MS and NMR [225] 
and combination of NMR and LC/MS was used to evaluate metabolic profiles of 
patients with albuminuria [226]. 
1.3.4 Metabonomics Data Analysis 
An NMR or MS spectrum of a biofluid sample can be considered as an object 
with a multidimensional set of metabolic coordinates, whose values are the 
spectral intensities at each data point. As a result, the spectrum is a point in a 
multidimensional metabolic hyperspace. The initial objectives of metabonomics 
are: (1) to classify a spectrum based on identification of its inherent patterns of 
peaks and (2) to identify those spectral features responsible for the classification. 
Therefore, reducing the dimensionality of complex data sets is important in 
metabonomics to enable easy visualization of any clustering or similarity of the 
various samples. 
Principle component analysis (PCA) may be the most extensively used 
multivariate statistical technique in metabonomics. It can express most of the 
variance within a data set through a smaller number of factors or principal 
components (PC). Each PC is orthogonal and independent of other PCs. Since the 
important PCs can describe the noise variation in the spectra simply, the variation 
in the spectral set is usually described by fewer PCs. Each PC consists of “scores” 
and “loadings”, where “scores” means a set of values defining the position of each 
sample in the new coordinate space and “loadings” defines a set of values giving 
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the relative contributions of each variable in calculating the scores. As a result, the 
multidimensional metabolic coordinates can be approximated by totaling the 
products of each set of scores by the corresponding set of loadings. 
Since PCA provides a reduced dimensional model that summarizes the major 
variation in the data into a few axes, it can be used to monitor the systematic 
variation, which can visualize the similar or dissimilar samples in a data set and 
the spectral regions, corresponding to biomarkers, that causes the 
treatment-related separation. Due to this important value, PCA has been exploited 
extensively in metabonomic toxicology [228, 229]. PCA can also be used for 
classification through soft independent modeling of class analogy [230, 231]. 
Firstly, an individual PCA model is established for each class of samples, 
followed by fitting the new samples to each model and classifying to the 
model/class that produces the lowest residual. 
Partial least squares or projection to latent structures (PLS), a widely used 
supervised method, derives a model that describes the correlation between the data 
matrix containing independent variables from samples, such as spectral intensity 
values (an X matrix) and the matrix containing dependent variables (e.g., 
measurements of response, such as toxicity scores) for those samples (a Y matrix). 
It can be used to predict the dependent variables when presented with new data 
and inform us about importance of each variable in prediction. PLS combined 
with discriminant analysis (DA) can also be applied to classification problems. 
1.4 Research Scope 
The primary objective of this dissertation is to expand the analytical applicability 
of sample preparation methods and capillary electrophoresis to Chinese herbal 
medicines and develop a targeted data processing approach for the metabolic 
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profiling of alkaloids in rat model with multiple analytical approaches. 
Since there are so many kinds of TCMs around the world and various research 
directions on TCMs, it is impossible to cover every aspect in this dissertation. 
Instead, two kinds of alkaloids existing in TCMs were selected for this study. 
Pyrrolizidine alkaloids (PAs), widely distributed in TCMs around the world, was 
investigated first. Different sample preparation methods such as 
microwave-assisted extraction (MAE), pressurized hot water extraction (PHWE) 
and heating under reflux were combined with LC/MS for isolation and 
determination of PAs. All the key factors affecting the extraction efficiencies were 
optimized. The results of this study provide an alternative tool for sample 
preparation of natural products in pharmaceutical industries or natural products 
research. 
Then a simple, economical and efficient NACE system was developed for the 
separation and determination of PAs in Chinese herbal medicine. The NACE 
conditions including buffer consistence and separation voltage were optimized. 
Subsequently, different on-line preconcentration methods of NACE were explored 
to enhance the sensitivity. All the parameters that could affect the preconcentration 
efficiency were optimized. The results of this study provide an alternative method 
for quality control in pharmaceutical industries to monitor those toxic compounds 
in natural products which would be harmful to human health. 
Berberine, a commonly used TCM in China, was chosen for the toxicity study in 
rat model. The metabolic profiling of berberine was investigated by NMR and 
LC/MS of urine samples, and GC/MS of tissue extracts. A new data processing 
method was used for PCA. The results of this study provided further insights on 
the potential therapeutic application of berberine. 
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The entire dissertation will be divided into two parts: Part I will focus on the 
separation and analysis of pyrrolizidine alkaloids in TCM, and Part II will focus 
on metabonomic studies of berberine in the rat model. 
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Chapter 2 Determination of Senkirkine and Senecionine in Tussilago Farfara 
using Microwave Assisted Extraction and Pressurized Hot Water Extraction 
with Liquid Chromatography Tandem Mass Spectrometry 
2.1 Introduction 
Tussilago farfara (Kuan Donghua), the dried flower bud of T. farfara L., is an 
important Chinese herbal medicine which has been commonly used for the relief 
of coughs and as an expectorant, blood pressure raiser, platelet activating factor 
and anti-inflammatory agent [1].It is also used for the treatment of asthma, 
silicosis, pulmonary tuberculosis, obesity, type 2 diabetes, and hepatitis [2–7]. 
However, besides therapeutic bioactive compounds present in the herb, it has been 
found to contain toxic pyrrolizidine alkaloids (PAs), mainly senkirkine and traces 
of senecionine (Figure 2.1) [8]. The PAs can be hepatoxic, causing damage to the 
liver and may even cause liver cancer when minute quantities are consumed 
[9–11]. As a result, in order to minimize the amount of toxic PAs ingested, the 
German health authorities have limited the daily intake of toxic PAs to 1µg. And 
in Austria only drugs and preparations free of 1,2-unsaturated PAs have been 
authorised since 1994 [8]. Therefore, in order to reduce the risk presented to 
consumers, it is very important to develop a simple method for the isolation and 
quantification of the toxic PAs in this herb. 
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Figure 2.1 Chemical structures of (A) senkirkine and (B) senecionine. 
Usually, the bioactive or marker compounds of T. farfara are extracted by soxhlet 
extraction [8], or by heating under reflux [8, 12–14]. However, these extraction 
methods are time-consuming and involve the use of large volumes of solvent. 
Recently, simpler and more environmental friendly extraction methods have been 
developed. These include supercritical fluid extraction (SFE), microwave-assisted 
extraction (MAE), pressurized fluid extraction (PFE) and so on. Their 
applicability in extraction of solid matrices and natural products has been 
discussed [15,16]. Among these new methods, MAE is applied on the extraction 
of a variety of sample matrices due to its faster extraction time and better 
extraction yields. This is because the heating by microwaves is instantaneous and 
occurs in the heart of the sample, leading to rapid extractions. Moreover, as the 
radiation can be focused directly onto the sample, microwave heating is more 
efficient and thus homogeneity and reproducibility improve significantly [16]. 
Until recently, MAE has been widely applied on the extraction of bioactive 
compounds from natural products, such as isolation of alkaloids from Rhizoma 
coptidis [17], Nelumbo nucifera leaves [18], Lycoris radiata [19] and Solanum 
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nigrum L. [20]. 
Pressurized hot water extraction (PHWE) is another extraction technique which 
can be applied for the isolation of bioactive or marker compounds from botanicals 
and medicinal plants while reducing or completely eliminating the use of organic 
solvents [21]. In PHWE, water is used as the extraction solvent at temperatures of 
100–350 ◦C and at a pressure high enough to keep it as a liquid. At elevated 
temperatures and pressures, the dielectric constant of water will be similar to those 
of ethanol or acetone. As a result, it can be used with other organic solvents to 
extract medium- or low-polarity compounds [22]. Until recently, PHWE has 
already been successfully applied to the extraction of less polar organic 
compounds from the environmental samples and traditional herbal medicines [21, 
23–26]. 
For the analysis and separation of PAs in T. farfara, analytical techniques such as 
gas chromatography [8], high performance liquid chromatography [12, 27], and 
capillary electrophoresis [12, 13] have been used. Sometimes, only the major 
alkaloid senkirkine, but not the minor alkaloid senecionine in T. farfara could be 
determined [8, 12, 14]. LC/MS is able to detect low levels of target compounds in 
a complex matrix as MS provides a second dimension (mass to charge) which 
separates co-eluting components. With tandem mass spectrometry, characteristic 
fragmentation pattern required for the rapid identification of unknown compounds 
can be obtained. To the best of our knowledge, the isolation, quantitative analysis 
and effects of ion suppression on senkirkine and senecionine in medicinal plant 
extracts using LC/MS have not been reported. Furthermore, reports on the rapid 
detection of major and minor components in the presence of co-eluting peaks in 
botanical extracts have been limited. 
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For the determination of PAs present in medicinal plants, proper sample 
preparation is of utmost importance. Thus, the aim of the current work is to 
develop a method for the rapid extraction and analysis of alkaloids such as 
senkirkine and senecionine using MAE and PHWE for determination by LC and 
LC/MS. The extraction efficiency of MAE and PHWE will be compared with that 
of heating under reflux. Concurrently, the effect of ion suppression in the 
botanical extracts will be investigated. 
2.2 Experimental 
2.2.1 Chemicals and reagents 
Methanol (HPLC Grade) and dichloromethane (HPLC Grade) were the products 
of Merck (Nordic European Center, Singapore). Absolute ethanol (HPLC Grade) 
was purchased from Fisher scientific (Loughborough, Leicestershire LE11 5RG, 
UK). Anhydrous ether (HPLC Grade) was obtained from Hayman (Witham, Essex, 
UK). Acetonitrile (HPLC Grade) was the product of Tedia (Fairfield, OH 45014, 
USA). Ultra-pure water was obtained by a NANOpure ultrapure water system 
(Barnstead Int., Dubuque, IA, USA). Formic acid was obtained from Fluka 
(Sigma–Aldrich pte Ltd., Science Park II, Singapore). Ammonium formate, sand 
(white quartz, 50–70 mesh, suitable for chromatography) and chlorpheniramine 
maleate were purchased fromSigma (St. Louis, MO, USA). Ammonium acetate 
was the product of Merck (Darmstadt, Germany). Powdered and dried flowers of 
T. farfara, aswell as crystallized standards of pyrrolizidine alkaloids were kindly 
provided by Health Sciences Authority, Singapore. 
2.2.2 Preparation of reference stantards 
Stock solution of senkirkine at 3000 mg/L was prepared in methanol. Senecionine 
was prepared at 2500 mg/L in methanol. For the LC analysis of MAE, the 
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working solutions of PAs were prepared in the calibration range of 5–200 mg/L in 
methanol. For the LC analysis of PHWE, the working solutions of PAs were 
prepared in the calibration range of 10–200 µg/L in methanol. 
2.2.3 Extraction 
2.2.3.1 Microwave-assisted Extraction 
A closed vessel system technique was employed using Marsx from CEM 
Corporation (Matthews, NC, USA). Powdered air-dried T. farfara flowers (1 g) 
were placed into a 100 mL Teflon extraction vessel with 40 mL of extraction 
solvent (Acidified to pH 2–3 with acid). Multiple extractions (2–3 samples 
simultaneously) were performed under different conditions. Samples were 
automatically stirred during the extraction process. The pressure in the vessel was 
set to be that of its own vapor pressure, and the temperature was set to be at 
boiling point of the binary mixture. After extraction, the vessel was allowed to 
cool to room temperature, extracts filtered, reduced to half volume, and extracted 
twice using dichloromethane, and twice using ether. The aqueous layer was then 
basified using 1M NaOH (pH 8–9) before it was extracted thrice using 
dichloromethane. The combined extracts were then evaporated to dryness using 
rotary evaporator and residues were dissolved in 1mL of methanol for analysis 
using HPLC and 5mL for analysis using LC–MS. The mixture was centrifuged at 
13,000 rpm for 15 min before it was analysed. 
2.2.3.2 Pressurized Hot Water Extraction 
The instrumentation of PHWE was the same as the one used by Ong et al. [21]. 
Briefly, the dimensions of the stainless steel columns obtained from Phenomenex 
were 10.0 mm ID×1/2 in OD×25 cm. The high pressure was generated by an 
isocratic Shimadzu LC 10 series pump (Kyoto, Japan). The pump flow was set at 
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1.5 mL/min and the pressure in the system indicated by the HPLC pump was 
between 15 and 23 bars. The elevated temperature for PHWE was maintained by a 
HP5890 GC oven (Hewlett-Packard, CA, USA). And a CLIC miniature back 
pressure regulator (Switzerland) was used to control the outlet flow. Generally 
0.25 g of the powdered and dried T. farfara was weighed directly in to a 50 mL 
plastic tube and mixed thoroughly with around 15 mL sand. The mixture was then 
transferred to the extraction cell, whose ends were filled with cotton. The cell was 
pre-filled with extraction solvent to check the possible leakage before setting the 
temperature to a certain value. 
The extraction efficiency was investigated with extractions at various 
temperatures of 60 ◦C, 80 ◦C, 100 ◦C and 120 ◦C for 40 min. The extract collected 
was rota-evaporated or heated to less than 50mL, followed by being transferred to 
a 50 mL volumetric flask. The kinetic study of PHWE was performed by 
collecting extracts at an interval of 10 min over a period of 80 min. In between 
runs, the system was washed with methanol in water (1:1) for 5 min. 
2.2.3.3 Heating under Reflux 
Powdered air-dried T. farfara flowers (1 g) were placed in a 150mL round bottom 
flask with 60mL of solvent. 1M HCl was added dropwise such that the pH of the 
resulting solution fell to around 2–3. A condenser was fitted to prevent solvent 
loss from occurring and the mixture was refluxed for 60min. The mixture was 
cleaned up in the same way as described in MAE section. 
2.2.4 LC and LC/ESI-MS analyses of MAE Extracts 
HPLC analyses were performed on an Agilent 1100 HPLC instrument 
(Waldbronn, Germany) coupled to binary gradient pump, autosampler, column 
oven, and diode array detector. Detection wavelength was set at 220 nm. 
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For the analysis of MAE extracts by HPLC, the samples were separated on a 
Waters Xterra C18 column (5 µm, 3.9 mmൈ150 mm, USA). The gradient elution 
involved a mobile phase consisting of (A) 0.1% formic acid in 20 mM ammonium 
acetate and (B) 0.1% formic acid in acetonitrile. The initial condition was set at 
10% B, gradient up to 40% B in 20 min before returning to initial conditions for 
10 min. The oven temperature was set at 40 ◦C and flow rate was set at 0.7 
mL/min. For all experiments, volumes of 10 µL of the diluted standards and 
samples were injected. 
For LC/ESI-MS analysis, the system comprised of an Agilent 1100 series 
(Waldbronn, Germany) binary gradient pump, autosampler, column oven, diode 
array detector and a LCQ-Duo ion trap mass spectrometer (ThermoFinnigan, San 
Jose, CA, USA). 
ESI-MS was performed in the positive mode. The LCQ mass spectrometer was 
operated with the capillary temperature at 270 ◦C, sheath gas at 80 (arbitrary units) 
and auxillary gas at 20 (arbitrary units). The target was fixed at 2×107 ions and the 
automatic gain control was turned on. The electrospray voltage was set at 4.5 kV, 
the capillary voltage at 10 V and lens tube offset at 0 V. Mass spectra were 
recorded from m/z 100–800. 
The ESI-MS spectrum was acquired in the positive mode. The instrument was 
operated in the selected ion monitoring (SIM) mode, where m/z of 336, m/z of 366 
and m/z of 230 were isolated. The product ions from 100 to 800 were collected. 
The heated capillary temperature was maintained at 350 ◦C, the flow rate of drying 
gas was set at 10 L/min and the pressure of nebulizer nitrogen gas was 50 psi, 
respectively. The target was set at 30,000, maximum accumulation time: 300 ms, 
the number of average scans was 5spectra/s and Smart-SelectTM was used. 
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Linearities for PAs were established between 5 mg/L and 200 mg/L (correlation 
coefficient≥0.99). S/N was at least 3 for peak identification. To quantify the two 
compounds in the medicinal herb, a three-point calibration based on the linearity 
established was used. The R.S.D.s (n = 6) for senkirkine and senecionine were 
found to be less than 5% on different days. 
2.2.5 LC/ESI-MS analyses of PHWE Extracts 
For LC/ESI-MS analyses of PHWE extracts, the gradient elution consisted of 
mobile phase of (A) 30 mM ammonium formate with 0.1% formic acid and (B) 
acetonitrile with 0.1% formic acid. The initial condition was set at 5% B, gradient 
up to 100% B in 15 min before returning to initial condition for 10 min. Oven 
temperature was set at 50 ◦C and flow rate was set at 0.2 mL/min. For all 
experiments, 5 µL of standards and sample extracts were injected. The column 
used for separation was Luna 3u C18 (2) 100A, 100 mm × 2.0 mm (Phenomenex, 
Torrance, CA, USA). All the conditions for ESI-MS were the same as mentioned 
above. Linearitis of PAs were established between 10 and 200 µg/L for LC/MS 
with correlation coefficients of r2 ≥0.99. And the three-point calibration based on 
the linearity established was used to quantify the two compounds in the medicinal 
herb. The R.S.D.s (n = 6) for senkirkine and senecionine was found to vary from 
0.6% to 5.4% on different days. 
2.3 Results and Discussion 
2.3.1 HPLC separation of MAE extract 
2.3.1.1 HPLC separation with UV detector 
The optimized separation conditions were applied to the MAE extracts of T. 
farfara. The content of senkirkine in samples of T. farfara was found to be present 
from 19.5 ppm to 46.6 ppm. For senecionine, it was either not detected or present 
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in less than 1 ppm [8]. From the chromatograms obtained, co-eluting peaks were 
observed with the analyte, senkirkine, before any clean-up step was performed 
(Figure 2.2A). In order to determine the amounts of PAs present in the plant 
extract, a clean-up step to remove co-eluting substances was performed to 
quantitate senkirkine accurately (Fig. 2.2B). Based on other reports, a clean-up 
step with solid phase extraction with diol or cation exchange cartridges was used 
[8, 28–29]. For the current work we used a liquid–liquid extraction clean-up step 
as reported earlier [12]. To check if the co-eluting peaks had been removed 
efficiently, UV spectra (not shown) were obtained for the senkirkine peak in the 
botanical extract and compared against that obtained using a standard. From the 
UV spectra obtained, it can be seen that the clean-up step has effectively removed 
the co-eluting components as the UV spectrum of the peak from the sample 
closely resembles that of the UV spectrum of the peak from the standard. 
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Figure 2.2 Chromatogram of Tussilago farfara extract A) before clean-up step, 
and B) after clean-up step. Running conditions are as stated above. 
 
2.3.1.2 Optimization of MAE 
As the pyrrolizidine alkaloids exist mainly in basic form, the alkaloids are usually 
extracted in acidified solution with weak acids such as acetic acid or other strong 
acids [8, 12, 28, and 29]. For the current work, two different acids, acetic acid and 
HCl in MeOH: H2O (1:1) were tested with MAE under the identical experimental 
conditions. From the results obtained in Figure 2.3A, it can be seen that extraction 
using HCl gives better extraction efficiency. Hence, all further extractions were 
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done using solution acidified with HCl. 
The amount of microwave radiation absorbed is dependent on the dielectric 
constants of the solvents used. For the extraction of marker compounds in T. 
farfara, it was reported that a binary mixture of MeOH: H2O (1:1) gave better 
extraction efficiency compared to using purely just water or methanol itself [8]. 
Two different solvent mixture MeOH: H2O (1:1) and EtOH: H2O (1:1) were 
evaluated under the same experimental conditions. From the result in Figure 2.3B, 
MeOH: H2O (1:1) was able to give better extraction efficiency. Hence, MeOH: 
H2O (1:1) acidified with HCl was selected for all further works. Although the use 
of a closed vessel allowed the use of temperatures above the boiling point of the 
solvent, the boiling point of the binary mixture was chosen for the current work. 
This is to prevent any buildup of excessive vapor pressure in the vessel. An 
extraction time of 15min was selected as it was reported that extraction using 
MAE could be completed in less than 15 min [16, 30–33]. 
  


































Figure 2.3 Effect of different acids and solvents on microwave-assisted extraction 
for senkirkine using: A) different acids with MeOH: H2O (1:1) as solvent, and B) 
MeOH: H2O (1:1) and EtOH: H2O (1:1) as solvents with HCl. Values expressed as 
means ± S.D (n=2). 
 
To determine the extraction efficiency of MAE, the amount of senkirkine present 
in the same medicinal plant was compared with that obtained by heating under 
reflux. From Table 2.1, the amount of senkirkine in the medicinal plant extracted 
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by MAE was comparable to that obtained by heating under reflux. This shows that 
the conditions such as the extraction temperature and time of extraction for MAE 
were optimal. The recovery of the clean-up step using liquid–liquid extraction was 
found to be 103.1±3.7% (n = 3). 
Comparison between 
heating under reflux 
and MAE on 2 days 
Senkirkine (µg/g) 
Heating under reflux 
(n=2) 
MAE (n=3) 
Mean ± S.D. RSD (%) Mean ± S.D. RSD (%) 
Senkirkine 94.0 ± 4.2 4.50 111.7 ± 11.3 9.66 
Senkirkine 118.5 ± 0.04 0.04 123.6 ± 3.57 3.05 
Table 2.1 Comparison of MAE with heating under reflux for the analysis of 
senkirkine in Tussilago farfara by LC with UV detection. 
 
Taking into account the number of steps in the proposed procedures, sample size 
used and the non-homogeneity of the medicinal plant samples, the method 
precision for the current work was comparable with other reports for the 
determination of marker or bioactive compounds in medicinal plants by LC with 
UV detection [34–37]. 
The main reasons for the enhanced performance when using MAE over reflux 
extraction are the higher solubility of analytes in solvent and higher diffusion rates 
as a result of a more homogenous heating due to the principle of microwave 
heating. A more homogenous heating resulted in the strong solute-matrix 
interaction caused by van der Waals forces, hydrogen bonding and dipole 
attractions between solute molecules and active sites on the matrix to be disrupted. 
2.3.1.3 LC/ESI-MS analysis for MAE 
For the positive ion ESI experiments, senkirkine and senecionine showed a very 
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high tendency to form [M+H]+ at 366.3 and 336.2 respectively. The two 
compounds were injected into the ESI/MS system and then fragmented in the ion 
trap up to MS2 or MS3 using the collision induced dissociation (CID). The 
advantage of multistage MS is that further fragmentation can be induced when 
significant fragmentation pattern cannot be observed from the ESI/MS2 spectra. 
This can be seen for baicalin in Scutellariae radix and Salvinorin B in Salvia 
divinorum where significant fragmentation pattern was not observed with the MS2 
spectra and MS3 was required to generate characteristic fragmentation pattern [38, 
39]. As seen from each fragmentation pathways in Figure 2.4, the main losses 
were water and carbon monoxide. The losses of H2O and CO have been observed 
in the MSn spectra of natural occurring substances such as salvinorin A and others 
[38, 40]. The MS/MS experiments of senkirkine and senecionine (Figure 2.4A–C) 
provided characteristic fragmentation ions that were consistent with that of 
retrosine-type and otonecinetype alkaloids [28, 41]. The otonecine-type PA, 
senkirkine, showed characteristic fragment ions at m/z 150, and 168. The 
retronecine-type PA, senecionine, showed characteristic fragment ions at m/z 138 
and 120. The fragmentation pathways for both senkirkine and senecionine were 
consistent with other reports [28, 41]. 
 
 
Chapter 2 Determination of Senkirkine and Senecionine in Tussilago Farfara using Microwave-assisted 


















































































Figure 2.4 MS2 Fragmentation pattern of A) Senkirkine, B) Senecionine, and C) 
MS3 fragmentation pattern of Senecionine. 
 
For senkirkine, only MS2 spectra was collected as the abundance of daughter ions 
at m/z 347.9 [MH−H2O]+ and 338.0 [MH−CO]+ were low. The selection of lower 
m/z for MS3 did not give useful information. Thus, further fragmentation was not 
done for senkirkine. As for senecionine, the abundance of daughter ion at m/z 
308.0 [MH−CO]+ was high. From Figure 2.4B and C, it can be seen that the 
daughter ions at m/z 119.9 decreased while other ions at m/z 137.9 and m/z 152.9 
increased. Although both senkirkine and senecionine have similar chemical 
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structures, the fragmentation patterns can differ significantly. Finally, the 
characteristic fragmentation patterns for both senkirkine and senecionine are 
required for the rapid identification of unknown compounds in botanical extracts 
with reference to pure standards. 
For the determination of aristolochic acids in multi-components herbal remedies, a 
method without any clean-up or concentration steps with LC/MS2 had been 
developed [42]. To the authors’ best knowledge, reports on the use of LC/MS for 
identification of target compounds in the presence of co-eluting peaks in botanical 
extracts are rather limited. As seen in Figure 2.2A and B, when HPLC was used, 
long and tedious clean-up step had to be employed to remove co-eluting peaks 
before senkirkine could be detected. However, by using LC/MS in the SRM mode 
where ions of m/z of 336 and 366 were isolated and detected, trace component 
senecionine as well as senkirkine could be detected successfully without the use of 
any clean-up step (Figure 2.5). Despite the presence of co-eluting peaks and 
possible ion suppression, the presence of low level of senecionine in the extract 
can be detected confidently. This shows that the proposed method using LC/MS 
was sensitive and selective. From Table 2.2, we can see that the comparable 
extraction efficiency was obtained between MAE and heating under reflux 
extraction. The limits of detection (LODs) and limits of quantitation (LOQs) of 
the MAE method developed were found to be 0.26µg/g and 1.32µg/g, 0.47µg/g 
and 1.80µg/g for senkirkine and senecionine respectively. 
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RT: 0.00 - 29.99






















































Figure 2.5 A) Total ion chromatogram (TIC) of Tussilago farfara extract before 
clean-up step. B) Extracted ion chromatogram (EIC) of senecionine observed at 
m/z 336 and C) EIC of senkirkine observed at m/z 366. 
 
2.3.2 HPLC analysis for PHWE 
2.3.2.1 LC/ESI-MS analysis for PHWE 
A LC/ESI-MS method without the use of splitting was used for the analysis of 
senkirkine and senecionine in the herbal medicine. Linearities for senkirkine and 
senecionine were established between 10µg/L and 200µg/L (correlation 
coefficient≥0.99). The relative standard deviation (R.S.D.) values of the peak 
heights for senkirkine and senecionine were observed to vary from 0.6% to 5.4% 
and 3.0% to 4.2% (n = 6) respectively on different days. 
2.3.2.2 Optimization of PHWE 
The main parameters that can affect the extraction efficiency of PHWE are 
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pressure, temperature, extraction time and addition of organic modifiers [21, 
43-44]. Generally, the pressure has little effect on the extraction efficiency since it 
is only for maintaining the extraction solvent in liquid state at elevated 
temperature [45–47]. For the current work, the optimal extraction solvent in MAE 
was also used in PHWE. As a result, temperature and extraction time were the 
main parameters considered. Since the physicochemical properties of water such 
as viscosity, surface tension, diffusibility, and solvent strength could be changed 
at elevated temperature, they could affect the solubility of the target compound in 
water. Since significant changes in the extraction efficiency from 60 ◦C to 120 ◦C 
were not observed in Figure 2.6, a temperature of 60 ◦C was chosen as the 
optimized temperature. Figure 2.7 shows that most of the main PA, senkirkine, 
was extracted out after 50min, while most of senecionine was extracted out after 
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Figure 2.6 Effect of different extraction temperatures on the recoveries of (A) 
senecionine and (B) senkirkine by PHWE (n=3) with flow rate: 1.5 ml/min for 40 
min.






































































Table 2.2 Comparison of MAE between heating under reflux and PHWE between heating under reflux. 
Conc. of alkaloids on 2 days 
(µg/g) 
 Comparison between MAE and heating under reflux  Comparison between PHWE and heating under reflux 
 MAE (n=3)  Heating under reflux (n=2)  PHWE (n=6)  Heating under reflux (n=2) 
 Mean ± S.D. RSD (%)  Mean ± S.D. RSD (%)  Mean ± S.D. RSD (%)  Mean ± S.D. RSD (%) 
Senkirkine (Day 1)  102.2 ± 10.6 10.4 109.6 ± 7.1 6.5 85.28 ± 5.00 5.9 84.78 ± 3.14 3.7 
Senecionine (Day 1)  2.16 ± 0.08 3.7 2.65 ± 0.04 1.5 3.20 ± 0.19 5.9 3.05 ± 0.04 1.3 
Senkirkine (Day 2)  112.8 ± 11.5 10.2 118.6 ± 8.3 7.0 80.95 ± 2.45 4.0 84.70 ± 3.73 5.8 
Senecionine (Day 2)  2.57 ±0.12 4.7 2.76 ± 0.15 5.4 3.18 ± 0.16 5.0 3.30 ± 0.18 5.5 
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The extraction efficiencies of pyrrolizidine alkaloids in T. farfara by PHWE were 
found to be comparable with heating under reflux extraction (Table 2.2). The 
method precision (R.S.D.) was found to vary from 4.0% to 5.9%. The LODs and 
LOQs of the PHWE method established were found to be 1.04 µg/g and 5.29 µg/g, 
0.72 µg/g and 2.86 µg/g for senkirkine and senecionine respectively. From Table 
2.2, we can also see that there are some differences between the two sets of results 
for heating under reflux extractions. This might be due to the batch to batch 
variation. 
2.3.3 Matrix-induced interference 
Ion suppression is one form of matrix effect that is a major concern in LC/MS 
techniques. It is typically observed in sample extracts from biological samples and 
is most possibly caused by the high concentration of nonvolatile materials present 
in the spray with the analyte. Any co-eluting nonvolatile solute such as salts may 
cause the suppression of ionization, giving rise to irreproducible results. Ion 
pairing agents, surface activities of the analyte and interfering compounds may 
also play an important role in ionization suppression [48]. Modifying instrumental 
components and parameters, chromatographic separation and sample preparation 
are strategies to reduce or eliminate ion suppression. Various calibration methods 
can be applied to compensate this effect. Standard addition is an effective method 
and is able to give good results even with variable matrices [49]. For the analysis 
of naturally occurring substances in botanical extracts, the effect of ion 
suppression was often not investigated [50–54]. As for the analysis of 
Toosendanin in the botanical extracts carried out using external standard 
calibration, the effect of matrix induced interference was investigated and 
significant ion suppression was not observed [55]. For plant analysis, standard 
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addition experiments remained to be the most effective method for the evaluation 
of ion suppression in LC/MS. From the chromatograms obtained in Fig. 2B, the 
presence of senkirkine was confirmed by the retention time and the UV spectra 
with the standard compounds. The effect of ion suppression or matrix induced 
interference in the botanical extracts was investigated using the standard addition 
method. For extracts obtained from MAE, the internal standard calibration plot (y 
= 0.0024x−0.035, y = 0.0031x + 0.075) and the standard addition (with the use of 
internal standard) plot (y = 0.0025x+0.1831, y = 0.0031x + 0.4857) were 
essentially parallel for both senecionine and senkirkine respectively. For extracts 
obtained from PHWE, the external standard calibration plot (y = 4321.1x−7089.6, 
y = 2774.9x−4978.7) and the standard addition (without the use of internal 
standard) plot (y=4112x + 97678, y = 2986.7x + 122142) were also essentially 
parallel for both senecionine and senkirkine. Hence, it can be deduced that without 
the use of any sample clean-up steps, significant ion suppression was not present 
even for the analysis of low level of senecionine in the plant extract. 
2.4 Conclusion 
In this work, both the combination of MAE and PHWE with LC/MS allowed for 
the simple, rapid isolation and quantification of the major and the minor 
pyrrolizidine alkaloids in T. farfara. Using LC/MSn, characteristic fragmentation 
pattern for both senkirkine and senecionine were obtained which could be used for 
the rapid identification of unknown compounds in botanical extracts with 
reference to a pure standard. Accompanied with the use of internal and external 
standard calibration, significant matrix-induced interferences or ion suppression in 
the presence of co-eluting peaks were not observed. As a result, the MAE and 
PHWE methods proposed in this work could be alternatives for the extraction of 
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bioactive or marker compounds in medical plants. 
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Chapter 3 Preconcentration and Separation of Toxic Pyrrolizidine Alkaloids 
in Herbal Medicines by Non-aqueous Capillary Electrophoresis (NACE) 
3.1 Introduction 
Pyrrolizidine alkaloids (PAs) are a class of natural products including about 350 
structures isolated from plants (especially Senecio, Eupatorium-Asteraceae, 
Crotalaria-Fabaceae, and Heliotropium-Boraginaceae) [1 – 3]. About 3% of all 
angiosperms contain these alkaloids. Until recently, more than 660 PAs and PA 
N-oxides have been identified in over 6,000 plants of these three families, and 
about half of them exhibit toxic activities [4]. Plants known or suspected to 
contain PAs are widely used for medicinal purpose as remedies all over the world 
[5]. For example, leaves of Tussilago farfara L. (Asteraceae), coltsfoot, are 
traditionally used to treat bronchial infections. However, this herb contains toxic 
PAs which can cause liver damage in minute quantities. As far as Senecio is 
concerned, it contains toxic PAs which have a cumulative poisonous effect when 
the whole herb is consumed [5]. So the risk to human health posed by exposure to 
these compounds has been a concern due to the wide distribution of toxic 
pyrrolizidine alkaloid-containing plants in the world. To avoid any risk to 
consumers, the German public health authorities limited the daily intake of toxic 
PAs to 1 µg. For use as herbal tea, the amount of these compounds in coltsfoot is 
limited to 10 µg /day [6]. As a result, quantitative analysis of Pyrrolizidine 
Alkaloids in these herbs plays an important role in avoiding the risks to 
consumers. 
Traditional Chinese medicine (TCM) has been used in China for treating illness 
for more than 2000 years. Many people in other Asian countries have also taken 
TCM for clinical practice or improving health for a long time. During the last two 
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decades, the use of Chinese herbal medicines in Europe, Australia, and North 
America for health care has been increasing. There are several different usage of 
the Chinese herbal plants; for new drug development, as natural remedies, 
functional foods (mixing functional herbs in conventional food), and dietary 
supplements. So the qualitative and quantitative analysis of active components in 
TCM have become very important. Tussilago farfara L. (Kuan Donghua) is a 
plant species which has been reported to be officially used as the plant source for 
TCM herbs among the 49 PA-containing Chinese herbal plants produced in China. 
It has been used to treat chronic bronchitis, asthma, and influenza [4]. Besides 
acidic polysaccharides, which are considered to be responsible for the cough 
relieving effect, the plant contains toxic pyrrolizidine alkaloids (PAs), mainly 
senkirkine and traces of senecionine [6]. Therefore, in order to utilize this plant 
more rationally and safely, it is necessary for us to develop a simple, economical 
and efficient method for the simultaneous separation and determination of these 
bioactive compounds in the plant. 
Until recently, several methods such as GC [7-8], HPLC [9] and photometric 
determination [10] have been employed for the analysis and quantification of PAs 
in coltsfoot. However, GC lacks resolving power and quantitative precision, while 
HPLC presents lower efficiency and is time-consuming. Therefore, it is necessary 
to establish a rapid and effective method for quantitative analysis of these 
alkaloids. 
Capillary electrophoresis (CE) has been widely used for the analysis of the 
components in herbal medicines because of its high resolution, minimum sample 
volume, short analysis time, and high separation efficiencies. Various alkaloids 
contained in herbal plants have been separated and determined using different CE 
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modes, such as capillary zone electrophoresis (CZE), nonaqueous CE (NACE), 
and micellar electrokinetic chromatography (MEKC) [11–26]. However, due to 
the narrow optical path length and the small sample volumes that can be injected 
into the capillary, the sensitivity in CE is poor especially when using UV detection. 
In order to overcome this problem, the application of on-line preconcentration 
techniques is a much simpler and more economical method compared with 
improving the sensitivity of the detector, such as laser-induced fluorescence 
detection and mass detection. Recently, non-aqueous capillary electrophoresis 
(NACE) has been found to be a good alternative for the analysis of Chinese herbs, 
which are difficult to separate in aqueous media. Indeed, compared with aqueous 
systems, the different chemical and physical properties of organic solvents 
(viscosity, dielectric constant, polarity, auto-protolysis constant, electric constant 
conductivity, etc.) have shown several advantages in terms of selectivity, 
efficiency, rapidity, mass spectrum compatibility and analyte solubility and 
stability. And some on-line preconcentration techniques in NACE have been 
reported [27-35]. Among these stacking methods, large volume sample stacking 
(LVSS) and field-amplified sample stacking (FASS) are the simplest and most 
commonly used techniques. In LVSS, the sample is dissolved in a low 
conductivity buffer and the sensitivity is improved by enhancing the injection 
volume of the sample. In this condition, a typical peak broadening will happen 
with the increasing of the sample volume. Normally, the improvement of the 
stacking efficiency is not so high. While in FASS, a short zone of low 
conductivity is presented at the capillary inlet, across which an electric field up to 
several hundred times higher than that employed in normal CE is established. This 
will permit the charged analytes to be injected at high velocity. With the 
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electrokinetic injection, analytes are stacked at the boundary between the 
low-conductivity zone and the running buffer. 
To the best of our knowledge, the applications of NACE on the analysis of PAs in 
Tussilago farfara L. have not been reported. In this study, firstly, a highly 
selective NACE system will be developed for the separation and determination of 
the alkaloids in the Chinese herb, Tussilago farfara L. The effects of the 
concentrations of electrolyte, acetic acid, organic solvent and applied voltage will 
be investigated. Then the two on-line preconcentration techniques, LVSS and 
FASS will be established for the analysis of PAs in Tussilago farfara L. 
3.2 Experimental Section 
3.2.1 Materials 
Ammonium acetate and acetic acid (99.8%) were the products of Merck 
(Darmstadt, Germany). Methanol and ethanol (HPLC grade) were obtained from 
Fisher Scientific (Loughborough, Leicestershire LE11 5RG UK). Acetonitrile 
(ACN) ( HPLC grade) was purchased from Tedia (Fairfield, OH45014, USA). 
Deionized water (≥18 MΩ) used throughout the experiments was generated by a 
NANOpure ultrapure water system (Barnstead Int., Dubuque, IA, USA). PAs of 
senecionine, monocrotaline, senkirkine, and retrorsine (Chromadex, CA, USA) 
were provided by the Health Sciences Authority (HSA, Singapore). Chemical 
structures of these four PAs are shown in Figure 3.1. Tussilago farfara L (Kuan 
Donghua) (Eu Yan Sang, Singapore) were also provided by HSA. 
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Figure 3.1 Structures of PAs of senkirkine, monocrotaline, sesecionine and 
retrorsine. 
 
3.2.2 Instruments and methods 
A 65 cm with 50 cm effective length long fused-silica capillary of 50 µm ID and 
363 µm OD (Polymicro Technologies, Phoenix, AZ, USA) was used to carry out 
the experiments. A portable CE instrument, CE-P2 Auto sampler (CE Resources, 
Singapore) equipped with a UV-VIS detector (SPD-10AVP, Shimadzu, Japan) 
was utilized for the NACE-UV experiments. The pressure for hydrodynamic 
injection was set as 0.3psi. Direct UV detection was employed at a wavelength of 
200 nm. Data was collected by CSW software (DataApex, Czech Republic). 
When a new capillary was first used, it was rinsed with 1 M NaOH for 30 min and 
deionized water for 10 min. After each run the capillary was rinsed for 3 min with 
1 M NaOH and 3 min with deionized water, followed by 2 min with running 
buffer, then conditioned under the applied voltage with running buffer for 2 min in 
order to obtain highly reproducible electroosmotic flow (EOF). The buffer was 
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renewed after every two runs for good reproducibility. All operations were carried 
out at a temperature of 22oC. 
3.2.3 Standard sample and running buffer preparation 
The stock standard sample solutions were prepared by dissolving 5 mg of each PA 
into 1.5 mL methanol to obtain the final concentration of 3333.3 µg /mL. 
Methanol in water (50:50) was used to dilute the stock sample solutions to a 
desired concentration level. Stock solutions of ammonium acetate was prepared 
and kept in the refrigerator (4oC). Running buffer was prepared daily. 
3.2.4 Extraction of PAs in herbal medicines 
3.2.4.1 Heating under reflux 
Each of the pulverized herbal medicines (1 g) was refluxed for 30 min with 60 mL 
of 50% methanol acidified with citric acid to pH 2–3. After filtration (0.2 µm) 
the solution was reduced to half the volume and partitioned twice with 30 mL 
dichloromethane and twice with 30 mL ether in order to remove lipophilic 
accompanying substances. The aqueous solution was alkalized with 25% 
ammonium (pH 9–10) and the PAs, as free bases, were extracted by threefold 
partition each against 30 mL dichloromethane. The combined organic layers were 
evaporated to almost dryness and then the residue was redissolved in 1 mL of 
methanol [25]. 
3.2.4.2 Microwave-assisted extraction 
A closed vessel system technique was employed using Marsx from CEM 
Corporation (Matthews, NC, USA). Powdered air-dried Tussilago farfara flowers 
(1g) were placed into a 100mL Teflon extraction vessel with 40mL of 
CH3OH:H2O=50:50 (Acidified to PH 2-3 with acid). Samples were automatically 
stirred during the extraction process. The pressure in the vessel was set to be that 
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of its own vapor pressure, and the temperature was set to be at boiling point of the 
binary mixture. After 15 min extraction, the vessel was allowed to cool to room 
temperature. The clean-up steps were the same as mentioned in section 3.2.4.1. 
3.3 Results and discussion 
3.3.1 Optimization of NACE conditions 
3.3.1.1 Effect of concentration of acetic acid 
The acidity of the buffer has an effect on the separation because it determined the 
extent of ionization of each analytes. In this experiment the acidity of the buffer 
was modified by acetic acid. Hereby, the concentration of acetic acid ranging from 
0-4% (v/v) was examined to investigate the effect of concentration of acetic acid 
on the migration behavior. From Figure 3.2A and Figure 3.2B we can see that 
with the increase of the concentration of acetic acid, the migration time of PAs 
decreased and the apparent mobilities of PAs increased. This might be due to the 
excess H+ protonized the PAs, which move in the direction of the electroosmotic 
flow (EOF). Considering both sensitivity and resolution, 1% (v/v) of acetic acid 
was chosen as the optimal concentration. 
 
 




Figure 3.2A Effect of acetic acid concentration on the separation of PAs. Buffer: 
50 mM Ammonium Acetate and 20% (v/v) ACN in methanol medium, (1) 0% 
acetic acid; (2) 1% acetic acid; (3) 2% acetic acid; (4) 3% acetic acid; (5) 4% 
acetic acid. Capillary: 65 cm (50 cm to detector) x 50 µm i.d.; Applied voltage: 20 




Figure 3.2B Effect of acetic acid concentration on apparent mobilities of PAs. 
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3.3.1.2 Effect of concentration of ammonium acetate 
Buffer concentration has a significant effect on separation performance because it 
could influence the viscosity of electrolyte. In order to obtain the best resolution 
of PAs, the ammonium acetate concentration ranging from 25 mM to 100 mM 
was examined. Figure 3.3A and Figure 3.3B show that the migration time of PAs 
increased with ammonium acetate concentration increasing. Also the noise 
became higher with the increasing ammonium acetate concentration. This might 
be due to the higher Joule heating caused by the increasing conductivity of the 
buffer. It was found that the best sensitivity and resolution was obtained when the 
concentration of ammonium acetate was 50 mM. So the optimal concentration of 
ammonium acetate was chosen as 50 mM. 
 
 
Figure 3.3A Effect of ammonium acetate concentration on the separation of PAs. 
Buffer: 1% (v/v) acetic acid and 20% (v/v) ACN in methanol medium, (1) 25 mM 
ammonium acetate, (2) 50 mM ammonium acetate, (3) 75 mM ammonium acetate, 
(4) 100 mM ammonium acetate. 
  




Figure 3.3B Effect of ammonium acetate concentration on apparent mobilities of 
PAs. The experimental conditions are the same as Figure 3.3A. 
 
3.3.1.3 Effect of concentration of ACN 
Organic solvents used as buffer additives can influence the viscosity and dielectric 
constant of electrolyte, so they could cause the change of velocity of EOF and 
migration time of solute. The concentration of acetonitrile (ACN) ranging from 
10% (v/v) to 35% (v/v) was tested to see its effect on the separation. From Figure 
3.4A and 3.4B we can see that the apparent mobilities of PAs increased with 
increasing concentration of ACN. As the best resolution was obtained at the 
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Figure 3.4A Effect of acetonitrile (ACN) concentration on the separation of PAs. 
Buffer: 50 mM ammonium acetate and 1% (v/v) acetic acid in methanol medium, 
(1) 10% (v/v) ACN, (2) 15% (v/v) ACN, (3) 20% (v/v) ACN, (4) 25% (v/v) ACN, 
(5) 30% (v/v) ACN, (6) 35% (v/v) ACN.  
 
 
Figure 3.4B Effect of acetonitrile (ACN) concentration on apparent mobilities of 
PAs. The experimental conditions are the same as in Figure 3.4A. 
 
3.3.1.4 Effect of applied voltage 
The effect of applied voltage on the separation was examined in the range from 10 
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resolution directly. From Figure 3.5 we can see that the migration time decreased 
with the increase of applied voltage. And Table 3.1 shows that when the voltage is 
20 kv, the best resolution was reached. Hence, 20 kv was selected as the optimal 
applied voltage. 
Figure 3.5 Effect of applied voltage on the separation of PAs. Buffer: 50 mM 
ammonium acetate, 1% (v/v) acetic acid and 20% (v/v) ACN in methanol medium, 
(1) 10 kv; (2) 15 kv; (3) 20 kv; (4) 25 kv. Capillary: 65 cm (50 cm to detector) x 
50 µm i.d. Detection: 200 nm. 
 
Conditions Resolution between a and b 
Resolution 
between b and c 
Resolution 
between c and d 
V=10 kv 9.109 2.035 1.692 
V=15 kv 9.295 2.166 1.688 
V=20 kv 10.264 2.355 1.766 
V=25 kv 8.074 2.192 1.615 
Table 3.1 Resolution at different applied voltages. 
According to the work mentioned above, optimal separation was achieved with a 
fused-silica capillary column of 65 cm (50 cm to detector) × 50 µm i.d. and a 
running buffer containing 50 mM ammonium acetate, 1.0% (v/v) acetic acid and 
20% (v/v) acetonitrile in methanol medium. The applied voltage was 20.0 kV. The 
analytes were detected by UV at 200 nm. 
3.3.1.5 Linearity, precision, LODs and LOQs 
In order to evaluate the practical applicability of the proposed NACE method, 
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linearity, precision, LODs and LOQs were investigated using the optimal 
separation conditions (Table 3.2). The results show good linearity between the 
peak area (y) and the concentration (x) with a good regression coefficient (R2 ≥ 
0.9940) in the range of 8.3-166.7 mg/mL. The relative standard deviations 
(R.S.D.s) (n = 4) of the migration time and peak area for the four PAs varied from 
0.37-0.50% and 0.98-2.67%, respectively. LODs and LOQs for the four PAs 
varied from 1.30-5.36 and 4.36-17.99 µg/mL at signal-to-noise ratios of 3 and 10, 
respectively.




























Senkirkine y=0.077x+0.16 0.9960 0.50 0.98 8.3-166.7 5.36 17.99 
Monocrotaline y=0.064x+0.09 0.9991 0.38 1.34 8.3-166.7 4.34 14.24 
Senecionine y=0.129x+0.35 0.9991 0.37 2.67 8.3-166.7 2.19 7.15 
Retrorsine y=0.292x+0.81 0.9966 0.39 1.72 8.3-166.7 1.30 4.36 
Table 3.2 Linearity, precision, LODs and LOQs of NACE 
a y and x stand for the peak area and the concentration (mg/l) of the analytes, respectively. 
b the detection limit was defined as the concentration where the signal-to-noise ratio is 3. 
c the limit of quantification was define as the concentration where the signal-to-noise ratio is 10.




The NACE method proposed in this study was applied for the determination of 
PAs in Kuan Donghua. The sample solution was diluted one time with methanol 
in water (50%) for CE analysis. The typical electropherograms of Kuan donghua 
after extraction are illustrated in Figure 3.6. Only senkirkine was detected in Kuan 
donghua. Peaks were identified by comparison of the migration times and by 
spiking the standards into the sample solution. The concentration of detected 
senkirkine in Kuan donghua was calculated to be 79.1µg/g. 
 
 
Figure 3.6 The electropherograms of the standards mixture solution and the real 
sample. Buffer: 50 mM ammonium acetate, 1% (v/v) acetic acid and 20% (v/v) 
ACN in methanol medium; high voltage, 20 kv.; injection time, 10 s; injection 
pressure, 0.3 psi. Capillary: 65 cm (50 cm to detector) × 50 µm i.d. Detection: 200 
nm. Real sample solution was diluted one time with methanol in water (50%) 
before injection. 
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3.3.2 Optimization of online preconcentration conditions 
3.3.2.1 Large volume sample stacking (LVSS) 
In LVSS, the optimized buffer mentioned above was used as the background 
solution (BGS). The samples were prepared in a buffer with 100-fold lower 
concentration of ammonium acetate resulting in a low conductivity sample zone. 
After hydrodynamic injection was completed, +20 kV was applied to power the 
CE separation. This procedure permits the PAs to move rapidly in the sample zone, 
and then slowdown at the junction between the sample zone and the background 
solution. As a result, the samples become concentrated at the boundary. 
Firstly, the LVSS was applied to the 4 different PAs, respectively. From Figure 
3.7 we can see that with the increase of the length of sample zone, the peaks 
became broader and the peak height increased initially. However, when the length 
of sample zone reached a certain level, the peak height decreased. These would 
affect the efficiency of the stacking. Therefore, the LODs of the LVSS method 
decreased at first, and then increased, which can be seen in Figure 3.8. For 
senkirkine, senecionine and monocrotaline, the length of the sample zone could be 
up to 15 cm, while the length was 10 cm for retroesine. In short, the improvement 
in LOD for a 15 cm injection compared to a typical injection of 0.6 cm is 10, 20 
and 12 times greater for senkirkine, senecionine and monocrotaline. For retrorsine, 
the improvement is 160 times greater under the optimized sample zone length. 














Figure 3.7 CE electropherograms of the 4 PAs obtained by NACE and LVSS, 
respectively. (1) Senkirkine A: Normal NACE of 8.3 ppm senkirkine with the 
optimal conditions. LVSS: BGS: 50 mM ammomnium acetate, 1% (v/v) acetic 
acid, 20% (v/v) ACN in methanol; sample zone: 0.5 mM ammonium acetate, 1% 
(v/v) acetic acid, 20% (v/v) ACN in methanol. Sample injection length: (B) 5 cm, 
(C) 10 cm, (D) 15 cm and (E) 20 cm. (2) Senecionie A: Normal NACE of 8.3 ppm 
senecionine with the optimal conditions. LVSS: BGS: 50 mM ammomnium 
acetate, 1% (v/v) acetic acid, 20% (v/v) ACN in methanol; sample zone: 0.5 mM 
ammonium acetate, 1% (v/v) acetic acid, 20% (v/v) ACN in methanol. Sample 
injection length: (B) 5 cm, (C) 10 cm, (D) 15 cm, (E) 20 cm and (F) 25 cm. (3) 
Monocrotaline, experimental conditions were the same as (1). (4) Retrorsine, 
experimental conditions were the same as (1). 













0.6 5 10 15 20














Figure 3.8 LODs of the 4 PAs with LVSS, respectively. 
The peak broadening became even worse when the LVSS was applied to the 
mixture of 4 PAs. It became obvious that the sample could not be “focused” 
completely. Figure 3.9 shows typical CE electropherograms of PAs mixture when 
the normal NACE and LVSS modes were used. As a result, 2cm was chosen as 
the optimized sample zone length to obtain good resolutions. From Table 3.4, we 
can see that around 5.23-7.65 fold improvement in detection sensitivity was 
obtained under the optimal sample length. 




Figure 3.9 CE electropherograms of PAs obtained by NACE and LVSS. (1) 
Normal NACE of 4PAs (16.7ppm each) with the optimal conditions. LVSS: BGS: 
50 mM ammonium acetate, 1% (v/v) acetic acid, 20% (v/v) ACN in methanol; 
sample zone: 0.5 mM ammonium acetate, 1% (v/v) acetic acid, 20% (v/v) ACN in 
methanol. Sample injection length: (2) 1 cm, (3) 2 cm, (4) 5 cm. 
 
3.3.2.2 Field-amplified sample stacking (FASS) 
3.3.2.2.1 Choice of organic solvent plug 
For FASS of NACE, a short plug of organic solvent was pre-introduced into the 
capillary at the anodic end before the electrokinetic injection of the sample. The 
mixture of 4 PAs with 1% (v/v) acetic acid in methanol was injected at a potential 
of 10 kV for 20 s after a 10 s organic solvent plug was injected at a pressure of 0.5 
psi. ACN, MeOH, and EtOH were used as the pre-injected plug. From Figure 3.10 
we can see that when ACN was used as the organic solvent plug, the largest peak 
areas were obtained for all the four PAs. Even though the peak areas obtained 
from no plug were sometimes a little higher or compared with those obtained from 
ACN plug, ACN was still chosen as the organic solvent plug. This is because the 
repeatability of FASS with no plug is not ideal. 
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Figure 3.10 Effect of organic solvent plug on FASS. 
Sample: 7.5 ppm senkirkine, 6.25 ppm senecionine, 7.5 ppm monocrotaline and 
7.5 pm retrorsine, 1% (v/v) acetic acid in methanol. Buffer: 50 mM ammonium 
acetate, 1% (v/v) acetic acid, 20% (v/v) ACN in methanol. The organic solvent 
plug was pre-injected at 0.5 psi for 10 s. Sample was injected at +10 kv for 20 s. 
The separation voltage was +20 kv. 
 
3.3.2.2.2 Optimization of sample matrix 
As far as FASS is concerned, the difference between the conductivity of the 
sample matrix and the buffer is another parameter that could affect the stacking 
efficiency. The lower the conductivity of sample matrix, the higher the stacking 
efficiency. Here, 3 different kinds of sample matrixes were investigated. It can be 
seen from Figure 3.11 that samples dissolved in methanol give the highest 
stacking efficiency. As a result, methanol was chosen as the optimized sample 
matrix. 




Figure 3.11 Effect of sample matrix on FASS. 
Sample matrix: (A) 4 PAs, 1% (v/v) acetic acid in CH3OH:H2O=50:50, (B) 4 PAs , 
1% (v/v) acetic acid in H2O, (C) 4 PAs, 1% (v/v) acetic acid in CH3OH. All the 
other conditions were the same as Figure 3.10. 
 
3.3.2.2.3 Optimization of organic solvent plug injection time 
The effect of the ACN plug injection time on FASS stacking efficiency was 
investigated from 0 to 20 s at the pressure of 0.5 psi. Figure 3.12A shows that the 
peak heights of the 4 PAs increased when the ACN plug was injected from 0 to 10 
s at 0.4 psi. This is because the ACN plug provides a higher electric field at the tip 
of the capillary, which could improve the sample stacking procedure. Further 
prolongation of the injection time reduced the peak heights. The change of peak 
areas was similar to that of the peak heights as shown in Figure 3.12B. The 
resolutions also became poorer with the further longer injection time. Considering 
both of the stacking efficiency and resolution, 10 s was selected as the optimized 
injection time for ACN plug. 





Figure 3.12 Effect of organic solvent plug injection time on FASS. 
A: Overlaid CE electropherograms of FASS with different ACN plug injection 
time, (a) 0 s, (b) 5 s, (c) 10 s, (d) 15 s and (e) 20 s. 
B: Effect of ACN plug injection time on peak areas of 4 PAs. 
 
3.3.2.2.4 Optimization of sample injection time and injection voltage 
Herein, the effect of sample injection times (from 15 to 50s) and injection voltage 
(from 6 to 14 kV) on FASS were studied. Figure 3.13A and Figure 3.13B show 
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injection voltage. However, the resolution became poorer with the increasing of 
sample injection time or injection voltage. This might be caused by the PAs 
passing through the boundary between the ACN plug and the running buffer and 
dispersing into the running buffer. As a result, the stacking of the analytes became 
incomplete and the resolution decreased. High resolution and stacking efficiency 
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Figure 3.13 Effect of sample injection time and injection voltage on peak areas. 
 
According to the experiments mentioned above, the optimal separation and 
stacking conditions were obtained when the sample was injected at 10 kv for 35 s 
after preliminary pressure injection of ACN (0.5 psi) for 10 s and separated with 
the buffer containing 50 mM ammonium acetate, 1% (v/v) acetic acid, 20% (v/v) 
ACN in methanol at 20 kv. 
 
3.3.2.2.5 Linearity, precision, LODs and LOQs 
Since the stacking efficiency is not so significant for LVSS, only the linearity, 
precision, limits of detection and limits of quantification were investigated under 
the optimized conditions to evaluate the practical applicability of the proposed 
FASS method (Table 3.3). The results showed good linearity between the peak 
area (y) and concentration (x) with good regression coefficient (R2>0.9957) in the 
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ppm for senecionine. R.S.D.s (n=4) in migration time and peak area of the four 
PAs varied from 0.12 - 0.37% and 0.53 - 4.87%, respectively. Limits of detection 
(LODs) and limits of quantification (LOQs) for the four PAs varied from 
60.5-135.9 and 199.92-237.01 ppb at signal-to-noise ratios of 3 and 10, 
respectively. Table 3.4 shows the limits of detection (S/N=3) of different CE 
methods for the analysis of PAs. Compared with normal NACE as well as LVSS, 
sensitivity improvement ranging from 18.56 to 89.33 folds was realized for the 
studied PAs by the proposed FASS method and it permits the direct analysis of 
trace compound in Tussilago farfara L. (Kuan Donghua).

























Senkirkine y=0.113x-0.33 0.9957 0.12 0.53 0.47-7.5 60.5 203.11 
Monocrotaline y=0.292x+0.16 0.9976 0.23 3.90 0.47-7.5 135.9 445.75 
Senecionine y=0.150x+0.19 0.9964 0.27 4.87 0.39-6.25 61.2 199.92 
Retrorsine y=0.125x+0.22 0.9971 0.37 4.45 0.47-7.5 70.6 237.01 
Table 3.3 Precision, linearity, LODs and LOQs of FASS. 
a y and x stand for the peak area and the concentration (mg/l) of the analytes, respectively. 
b the detection limit was defined as the concentration where the signal-to-noise ratio is 3. 




Limits of detection (LOD, µg/mL)a and sensitivity enhancement (SE) 
NACE LVSS FASS 
LOD LOD SE LOD SE 
Senkirkine 5.36 0.87 6.16 0.06 89.33 
Monocrotaline 4.34 0.83 5.23 0.14 31.00 
Senecionine 2.19 0.39 5.62 0.06 36.50 
Retrorsine 1.30 0.17 7.65 0.07 18.56 
Table 3.4 Comparison of limits of detection (LOD) and sensitivity enhancement (SE). 
a the detection limit was defined as the concentration where the signal-to-noise ratio is 3. 
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3.3.3 Application to Real Sample 
The FASS method proposed was applied for the determination of PAs in Kuan 
Donghua. One gram pulverized powder of Kuan Donghua was extracted by using 
the MAE method described in section 3.2.4.2. The sample solutions were diluted 
10 times with methanol. The typical electropherogram of the standard mixture and 
Kuan Donghua is illustrated in Figure 3.14. Both the major senkirkine and minor 
senecionine were detected. Peaks were identified by comparison of the migration 
times and by spiking the standards into the sample solution. The concentration of 
detected senkirkine and senecionine in Kuan donghua were calculated to be 77.36 
and 2.86µg/g, respectively. The results were consistent with those obtained from 




Figure 3.14 Electropherograms of the standard mixture (A) and the real sample 
(B) under the optimum conditions. (a): senkirkine; (b): monocrotaline; (c): 
senecionine; (d): retrorsine. 




A simple, economical and efficient NACE method was developed for the 
separation and determination of PAs in the Chinese herbal medicine, Kuan 
Donghua. Two stacking methods, LVSS and FASS were established for the 
analysis of PAs in Kuan Donghua also. Compared with LVSS, FASS was found 
to be superior in this study in terms of sensitivity enhancement, which could 
provide 20-100 fold enhancements. Generally, this method provides a rapid and 
sensitive alternative approach for the analysis of PAs in plants and for the quality 
control of natural products. 
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Chapter 4 Metabolic Profiling of Berberine in Rats with gas 
chromatography/mass spectrometry, liquid chromatography/mass 
spectrometry and 1H NMR spectroscopy 
4.1 Introduction 
Berberine (Figure 4.1), an isoquinoline alkaloid of the protoberberine type, is 
derived from the root, rhizome, and stem bark of many plant species such as 
Coptis chinensis Franch., Coptis japonica Makino., Berberis thunbergii DC., 
Hydrastis canadensis L., and Thalictrum lucidum Ait. With the quaternary base in 
the chemical structure, the commercial product of berberine is generally prepared 
as a chloride or sulfate for clinical applications. Berberine has been commonly 
used for the treatment of gastroenteritis and secretory diarrhea in traditional 
Chinese medicine for a long history. To date, many pharmacological studies have 
been done on berberine. It was found that berberine also shows antimicrobial, 
anti-HIV, anti-inflammatory, antiarrhythmic, cerebroprotective, anticancer, 
vasorelaxing, antimutagenic, analgesic, antifungal, cardioprotective, 
immunoregulative, antimalarial, antioxidative and anxiolytic effects [1-17] and 
liver might be the metabolic site for berberine [18, 19]. However, the 
metabonomic studies on berberine have been limited. 
 
Figure 4.1 Chemical structure of berberine. 
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Metabonomics is defined as the quantitative measurement of the dynamic 
multiparametric metabolic response of a living system to pathophysiological 
stimuli or genetic modifications [20]. It is based on the analysis of endogenous 
metabolites of different kinds of biofluids and tissues extractions, and aims to 
explore a potential relationship between the changed metabolic profiles and the 
physiological status of the biosystem. As a result, it can augment and complement 
the information provided by measuring the genetic and proteomic responses to 
xenobiotic exposure. Metabonomics techniques have been found to be extremely 
useful tools for probing the mechanisms and evaluating the safety of traditional 
Chinese medicines [21-24]. 
As far as the analytical techniques used in metabonomics studies are concerned, 
high-resolution nuclear magnetic resonance (NMR) spectroscopy is the most 
commonly used technique. A lot of the original metabonomics studies were 
performed using NMR spectroscopy. The ubiquitous used 1H NMR has the 
advantages of being non-destructive, applicable to intact biomaterials and rich in 
structural information. It is an inherently robust technique which can report a 
number of compounds in a single measurement with minimal sample preparation. 
Today NMR spectroscopy has been extensively applied for metabonomics studies 
[25-36]. 
Another commonly used analytical technique is mass spectroscopy (MS) normally 
coupled with LC or GC. This technique provides much greater sensitivity and 
higher resolution than NMR spectroscopy. In addition, MS can provide useful 
information for molecular identification, especially using tandem MS (MS-MS) 
methods. However, the quantitation of analytes might be impaired by variable 
ionization and ion suppression effects. Recently, ultra performance liquid 
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chromatography (UPLC) has been introduced to improve the chromatographic 
peak resolution, separation speed and sensitivity. The application of 
chromatography-mass spectrometry to metabonomics has been reviewed [37]. In 
recent years, MS has been successfully used for metabonomics research [38-45]. 
At the same time, the combination of 1H NMR and MS has been used for the 
investigation of metabolic profiles associated with the effects of drugs and 
chemical substances [46-51]. They are highly complementary approaches for 
metabonomics studies, and the use of both techniques is often necessary for full 
molecular characterization. However, the manual processing and exporting of 
LC/MS data can be rather tedious [52, 53]. It was demonstrated that a targeted 
profiling with 1H NMR produced robust models, generated accurate metabolite 
concentration data and provided information that can be used to help understand 
metabolic differences in a healthy population [54-56]. However, the used of 
targeted profiling with LC/MS has not been reported. 
A successful metabonomics study can’t be achieved without the multivariate 
analysis. Principal components analysis (PCA) is one of the simplest techniques 
that have been used extensively in metabonomics. And most of the variance 
within a data set can be expressed by a smaller number of factors or principal 
components with PCA. For visualization, each sample would occupy a position 
based on its metabolite composition. As a result, it is much easier for us to 
investigate the evolution of metabolites. 
As the manual processing of LC/MS can be rather tedious, we use an approach 
based on targeted profiling with LC/MS. In this study, we report a comparison of 
urinary metabolites profiles from normal rats and rats treated with berberine (50 
mg/kg) using targeted profiling with LC/MS and non-targeted profiling with 1H 
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NMR. The current approach is used to study the urinary metabolic profiles 
associated with the glucose reduction, lipid and cholesterol lowering effects of 
berberine in the livers of Sprague Dawley rats. 
4.2 Experimental 
4.2.1 Chemicals 
Methanol and acetonitrile of HPLC grade were purchased from APS (NSW, 
Australia). Pure water was obtained from Millipore Alpha-Q water system 
(Bedford, MA, USA). Formic acid was purchased from Merck (Darmstadt, 
Germany). Valeric acid, L-leucine, D-serine, homocysteine, lysine, creatinine, 
phenylalanine and hippuric acid were purchased from Sigma (St. Louis, MO, 
USA). 
4.2.2 Animal Studies 
Rats (Sprague Dawley) were obtained from Laboratory Animals Centre, National 
University of Singapore. Animals were acclimatized in standard rodent cages with 
individual ventilation. The animal room was maintained at 25 + 2 oC with natural 
day/night cycle. Following a 7 day acclimatization period, animals were randomly 
allocated into 2 groups comprising 8 animals each. Food and water were provided 
ad libitum. The treatment group was administered berberine (Sigma, Singapore) at 
a dose of 50 mg/kg by intraperitoneal injection at 0 and 48 hours. All animals 
were housed individually in metabolism cages for the ease of urine collection. The 
control group received saline by intraperitoneal injection. Body weights of 
individual rats in each group were measured at the beginning of the experiment, 
weekly and at the time of sacrifice. All animals were sacrificed at the end of the 
experiment. Post mortem examination was done on all animals. The livers and 
kidneys of each rat from the control and treatment groups were preserved in 10% 
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buffered formalin solution for histopathological examination. 
4.2.3 Histopathological Examination 
The livers and kidneys of control and treated animals were processed and stained 
with hematoxylin and eosin. Sections were examined under the light microscope. 
4.2.4 Sample preparation for metabonomics profile of rat urine samples 
Samples of rat urine were collected during the same (9 to 12 noon) time interval 
daily for a total of 6 days after treatment. The rat urine collected from the control 
and treatment groups were stored frozen at –20oC prior to analysis. For HPLC 
assay, a 20 μl aliquot of rat urine was diluted to 100 μl with distilled water. 
4.2.5 Reversed-phased LC/MSMS 
For LC/MS assay, a 30 μL aliquot of urine was diluted to 70 μL with distilled 
water. An Agilent 1200 RRLC system (Waldbronn, Germany) equipped with a 
binary gradient pump, auto-sampler, column oven and diode array detector was 
coupled with an Agilent 6410 triple quadrupole mass spectrometer. The gradient 
elution involved a mobile phase consisting of (A) 0.1% formic acid in water and 
(B) 0.1% formic acid in acetonitrile. The initial condition was set at 5% of (B), 
gradient up to 100% in 10 minutes and returning to initial condition for 5 minutes. 
Oven temperature was set at 50°C and flow rate was set at 200 μL/min. For all 
experiments, 5 μL of samples were injected. The column used for the separation 
was a reversed-phase Zorbax SB18 (50 x 2.0 mm, 1.8 μm, Agilent Technologies, 
USA). The ESI-MS was acquired in the positive ion mode. The product ions of 
m/z range from 100 to 800 were collected. The heated capillary temperature was 
maintained at 350oC, the drying gas and nebulizer nitrogen gas flow rates were 
10L/min and 50 psi respectively. 
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4.2.6 Analysis of urine samples by 1H NMR 
300 µL of urine samples were buffered with 300 µL of 0.2 M phosphate 
buffer/D2O (pH7.4) prior to analysis by 1H NMR. The solutions were pipetted into 
NMR tubes (5mm O.D, 7 inch length, Sigma-Aldrich) and one dimensional 1H 
NMR spectra were obtained on a Bruker DRX500 operating at 500.15 MHz 
observation frequency. Water suppression was achieved by applying the standard 
Noesypresat pulse sequence (Bruker Biospin Ltd) with secondary irradiation of 
the dominant water signal during the mixing time of 150 ms and the relaxation 
delay of 2 s. Spectra were referenced to the internal reference standard TSP 
dissolve in D2O to provide a field-frequency lock. 
4.2.7 Analysis of liver samples by GC/MS 
Individual liver was dried in freeze dryer and extracted with 0.5 mL of 
CHCl3/CH3OH (3:1). After centrifugation at 161,000 rcf for 5 minutes, the 
supernatant was lyophilized. The dried sample (lipid fraction) was kept at -30 °C 
prior to analysis using GC/MS. For the liver tissue extract, the dried sample was 
reconstituted in 50 μL EA. 50μL of BSTFA, pyridine and EA (3:1:1, v/v/v) 
mixture was added to the tissue extract together with the standard solutions. The 
resulting solution was vortexed for 1 minute at room temperature and transferred 
to an amber glass vial for analysis using GC/MS. 
1.0 μL aliquot of the derivatized sample with standard was injected using the 
splitless mode with an Agilent 7683 Series autosampler (Agilent Technologies) 
into an Agilent 6890 GC system equipped with an Agilent HP-1MS capillary 
column (15 m × 0.25 mm; ID × 0.25 μm). The inlet temperature was set at 300°C. 
Helium was used as the carrier gas with a constant flow rate 1.40 mL/min through 
the column. The initial temperature was set at 100 °C. 1 minute after injection the 
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GC temperature was increased at a rate of 10 °C/min to 300 oC and held for 3 
minutes at 300 oC. The transfer line temperature was set at 300 oC. Detection was 
achieved using MS in electron impact mode and full scan monitoring (m/z 50 to 
800). The temperature of the ion source was set at 200 °C, and the quadrupole was 
set at 150 °C. 
4.2.8 Chemometric analysis 
Fourier transformed 1H NMR spectra were manually phased and baseline 
corrected using XWINNMR 3.5 (Bruker Biospin, Rheinstetten, Germany). Each 
spectrum was integrated between 0.5 to 4.5 and 5.1 to 10 ppm. The spectral region 
containing the water resonance was removed from all data sets prior to 
normalization and multivariate data analysis in order to eliminate variation due to 
water suppression efficiency. The resulting two-dimensional data, 1H chemical 
shift, and peak heights were generated. 
For GC/MS, each sample was represented by a GC/MS total ion chromatogram 
(TIC). The data was exported to Genespring 1.1.1 (Agilent Technologies, USA) 
for the determination of perturbed metabolites. Among the detected peaks, a 
multi-dimensional vector was constructed to characterize the biochemical pattern. 
Each vector was normalized to the total sum of vector intensity, thereby partially 
accounting for concentration due to different sample sizes used. Peaks due to 
column bleed and derivatization reagent were removed. The identification of 
peaks was based on the use of reference standards and NIST98 library. The mass 
spectra obtained were inspected manually and only those molecules with 
probability matching higher than 90% were considered. 
The resulting LC-MS data served as raw data for PCA analysis. The LC-MS data 
were peak-detected and noise-reduced such that only true analytical peaks were 
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further processed by the PCA software. For targeted profiling, a list of the peak 
areas of the peaks detected from Table 4.3A and Table 4.5A and m/z 100-110, 
200-210, 300-310 and 400-410 were then generated manually. The data was 
tabulated into Microsoft Excel for each sample run, using the retention tine (RT) 
and m/z data pairs as the identifier for each peak. The peak areas for each peak 
detected were then normalized within each sample, to the sum of the peak area in 
that sample. Normalization was required to remove concentration differences 
between dilute and concentrated urine samples. To account for any difference in 
concentration between samples, all 1H NMR and LC/MS data were normalized to 
a total value of 100. The resulting three-dimensional data for 1H NMR and LC/MS 
were analyzed by PCA. The resulting data were then exported to Simca-P+ 
Software package (Umetrics, Umea, Sweden) for subsequent processing by 
unsupervised and supervised methods.  For PCA, the data were reduced to 2 
latent variables (or principal components, PCs) that would describe maximum 
variations within the data. The PCs which were obtained from the scores would 
highlight clustering, trends and outliers in the observation direction in the data set. 
4.2.9 Statistical analysis 
From the normalized data obtained from LC/MS and 1H NMR, indication of 
significance was based on a two-tailed student t-test performed with SPSS 14.0 
for Windows (SPSS, Chicago, IL). For the identification of potential biomarkers, 
two-tailed student t-test (P < 0.05 and P<0.01) were used. 
4.3 Results and Discussion 
4.3.1 Results 
4.3.1.1 Body weight and histopathology 
The body weights of all the rats kept on increasing in the acclimatization period 
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(results not shown here). Figure 4.2 shows the trends of body weights of rats after 
the injection of saline and berberine. The body weights of the control group kept 
on increasing over the 5 days period. However, the body weights of the treatment 
group decreased after the administration of berberine. It was found that they had 
recovered from the berberine effect with slight increasing in body weights on day 
5. This phenomenon suggested the cholesterol lowering effect caused by berberine 























Figure 4.2 The trends of body weights of rats. The results shown are averages 
with standard deviations (n=8). (Blue: control group, red: treatment group) 
 
Histopathological findings after the administration of berberine are summarized in 
Figure 4.3. Significant changes on liver and kidney pathology were not observed 
in the treatment group. 
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(A)                                    (B) 
       
(C)                                    (D) 
Figure 4.3 Histopathological photomicrographs of rat livers and kidneys from 
control group and treatment group with dose of 50 mg/kg of berberine. H&E 
staining, Magnification 400×. (A) control rat liver, (B) treated rat liver, (C) control 
rat kidney, (D) treated rat kidney.  
 
4.3.1.2 Determination of metabolites in rat livers samples by GC/MS 
A capillary GC/MS using EI was carried out after the derivatization of the liver 
extracts. Figure 4.4 shows the representative GC/MS chromatograms for the lipid 
fraction of liver extracts. Significant information can be obtained by visual 
examination of the TICs from the liver samples of the control and treatment 
groups. The two groups exhibited unique metabolic profiles. 
For the GC/MS data, the peak areas were normalized to a constant sum and the 
PCA score plot (Figure 4.5A) shows two distinct clusters for data obtained from 
the lipid fraction of liver extracts of both control and treatment groups. From 
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Figure 4.5A we can also see that the control group was clustered in a small region. 
This might be due to the biological variation. 
The perturbed metabolites detected using GC/MS on different liver extracts are 
shown in Figure 4.5B. Metabolites that were observed to be significantly different 
(based on a two-tailed Student’s t-test) in the livers of the control and treated rats 
included cholesterol, glucose, maltose and fatty acids. The compounds that were 
found to be lower in the treated group included cholesterol, glucose, maltose, 
butanoic acids, propanoic acids, tetradecanoic acid, palmitoleic acid, arachidonic 
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Figure 4.4 Typical GC/MS chromatograms of the lipid fraction of rat liver 
extracts. 
(A) cholesterol, (B) glucose and (C) total ion chromatogram (TIC) of the lipid 
fraction of rat liver extracts. (Black: control group, Blue: treatment group) 
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6)5,8,11,14,17 eicosapentaenoic 
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from all the control (n=8) and treatment group (n=8) (PCA component 1: 34.7 % 
variance, PCA component 2: 17.1 % variance), 
(B) Simplified pathway illustrating perturbed metabolites in the rat liver samples 
between the control and treatment group. The statistics are as follows: significant 
difference between the control group (n=8) and treatment group (n=8) is based on 
two tailed student t test (* p<0.05, ** p<0.01). 
 
4.3.1.3 Determination of metabolites in rat urine samples by 1H NMR 
A typical time course of 1H NMR spectra of the pre-dose and treatment groups’ 
urine samples acquired using the standard 1D pulse sequence for water 
suppression is shown in Figure 4.6. It can be seen from Figure 4.6 that there exist 
differences in some of the peak intensities, suggesting that the two groups might 




Figure 4.6 Typical 1H NMR spectrum (0-5 ppm) of rat urine samples obtained 
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The metabolites being identified had their resonance determined previously and 
the compounds that can be detected included the amino acids, carboxylic acids, 
ketone bodies and methylamines, and others. The 1H chemical shift assignments 
of the metabolites in the rat urine samples were based on other reports and online 
databases [57-61]. The completed data were summarized in Table 4.5 (Appendix). 
After the administration of berberine, an elevation in creatine, glucose and glycine 
was observed. Decreases in tryptamine, tyrosine, α-ketoglutarate, dimethylglycine, 
trimethylamine (TMA), aspartic Acid, glutamine, succinate and leucine were also 
observed. Table 4.1 shows the selected metabolites identified in rat urine samples 
for both control and treatment group on different days. The changes of these 
selected components were more significant on the next day of berberine 
administration. Figure 4.7 shows the changes of other selected metabolites as 
measured by 1H NMR on different days. From Figure 4.7 we can see that pyruvate 
could recover from the berberine effect while glucose and lactate couldn’t. The 
concentrations of glucose and lactate were higher in the treatment group than in 
the control one.
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 Normalized peak intensitya 







 Pre-dose       
1 Fumurate 6.53 s 0.18 0.04 0.17 0.04 
2 Creatinine 3.08 s 0.15 0.03 0.15 0.07 
3 Lysine 3.74 t 0.41 0.21 0.38 0.26 
4 Citrate 2.60 d 0.32 0.05 0.34 0.06 
 Citrate 2.50 d 0.37 0.07 0.32 0.08 
        
 Day 1       
1 Fumurate 6.53 s 0.26 0.03 0.23 0.09 
2 Creatinine 3.08 s 0.21 0.03 0.17 0.06 
3 Lysine 3.74 t 0.65 0.27 1.79 1.48 
4 Citrate 2.60 d 0.34 0.04 0.28 0.08 
 Citrate 2.50 d 0.41 0.09 0.49 0.38 
        
 Day 2       
1 Fumurate** 6.53 s 0.27 0.02 0.13 0.06 
2 Creatinine** 3.08 s 0.19 0.03 0.33 0.04 
3 Lysine** 3.74 t 0.71 0.10 1.08 0.19 
4 Citrate 2.60 d 0.28 0.12 0.32 0.08 
 Citrate 2.50 d 0.36 0.09 0.41 0.03 
        
 Day 3       
1 Fumurate 6.53 s 0.20 0.03 0.31 0.33 
2 Creatinine* 3.08 s 0.25 0.03 0.13 0.12 
3 Lysine* 3.74 t 0.91 0.11 2.58 1.94 
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4 Citrate 2.60 d 0.32 0.13 0.15 0.13 
 Citrate 2.50 d 0.30 0.05 0.17 0.16 
        
 Day 4       
1 Fumurate 6.53 s 0.15 0.04 0.14 0.07 
2 Creatinine** 3.08 s 0.18 0.03 0.27 0.06 
3 Lysine** 3.74 t 0.48 0.06 0.77 0.17 
4 Citrate 2.60 d 0.30 0.03 0.44 0.21 
 Citrate 2.50 d 0.36 0.14 0.39 0.07 
aThe relative intensity of metabolites is expressed with their normalized peak area. Values are represented as 
mean ±SD (standard deviation). The statistics are as follows: significance difference between the control 
group (n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
Table 4.1 Selected metabolites identified in rat urine samples for both control and treatment group as measured by 1H NMR. 















































Figure 4.7 Changes of selected metabolites as measured by 1H NMR on different 
days (blue colour: control group, n=8, pink colour: treatment group, n=8).  
(A) Glucose, (B) Pyruvate and (C) Lactate. 
 
For the 1H NMR data, the peak heights were normalized to a constant sum to 
compensate for the differences in overall concentration between individual urine 
samples. The PCA scores plots of the control and treatment groups are illustrated 
in Figure 4.8. The plot indicates that there exists a separation between the control 
and treatment groups. It suggests that there might be a difference in the metabolic 
urinary excretion of metabolites from the two groups.























































Figure 4.8 Data analysis of 1H NMR rat urine metabolic profiles.  
(A) PCA scores plot for data from all rat urine samples collected on day 1; 
(B) PCA scores plot for data from all rat urine samples collected on day 2; 
(C) PCA scores plot for data from all rat urine samples collected on day 3; 
(D) PCA scores plot for data from all rat urine samples collected on day 4; 
(Black: control group, red: treatment group). 
(E) PCA scores plot for data from all rat urine samples collected (black triangle: 
control group from day 0, black open square: control group at day 4 and red 
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Figure 4.9 and Figure 4.10 demonstrate the integrated metabolic profile on day 4. 
 
Figure 4.9 Simplified pathway illustrating perturbed metabolites in the rat urine 
samples on day 4 between the control and treatment group. The statistics are as 
follows: significance difference between the control group (n=8) and treatment 
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1) adipic acid ↑* 
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5) stearamide ↑* 
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Figure 4.10 Simplified pathway illustrating metabolites involved in purine 
metabolism in the rat urine samples on day 4 between the control and treatment 
group. The statistics are as follows: significance difference between the control 
group (n=8) and treatment group (n=8) is based on two tailed student t test (* 
p<0.05, ** p<0.01). 
 
4.3.1.4 Determination of metabolites in rat urine samples by LC/MS 
Urine is of interest in metabonomics studies because its collection is non-invasive 
and it actually amplifies the circulating levels of metabolites by renal 
concentration, which consequently provides a distinct representation of metabolic 
response. The composition of rat urine is very complicated. It contains amino 
acids, organic acids, amines, lipids, sugars, peptides and metabolic end products 
such as sulfate and glucuronide conjugates. In this study, both the positive and 
negative modes were carried out for the LC/MS analyis of rat urine samples. 
Figure 4.11 demonstrates the quantitative and qualitative differences between the 
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the positive ESI/MS of urine samples. Visual inspection of the data suggested that 
the two groups may have different metabolic profiles. 
 
Figure 4.11 Typical total ion chromatograms (TIC) of rat urine samples obtained 
from control group (black) and treatment group (red) using LC/MS (positive 
mode). 
 
As seen in Table 4.3 (Appendix), there were several peaks in the urine samples 
from the treatment group that showed significant changes when compared to urine 
samples from the control group when the positive mode was used. And there were 
also significant changes when the negative mode was applied (Table 4.4, 
Appendix). Table 4.2 shows the selected metabolites identified in rat urine 
samples for both the control group and treatment group as measured by LC/MS 
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 Normalized peak intensitya (%) 
NO. Metabolite Retention Time 
(min) 
m/z Control Ave ±SD Treated 
Ave 
±SD 
 Predose        
1 Fumaric Acid 1.00 115 0.0227 0.0118 0.0263 0.0205 
2 Creatinine 0.80 114 6.09 1.08 5.55 1.10 
3 Lysine 0.62 147 0.038 0.018 0.050 0.017 
4 Citric Acid 0.94 191 6.10 1.51 5.97 1.71 
        
 Day 1       
1 Fumaric Acid 1.00 115 0.0247 0.0071 0.0247 0.0170 
2 Creatinine* 0.80 114 3.88 0.56 6.49 2.51 
3 Lysine 0.62 147 0.052 0.018 0.056 0.018 
4 Citric Acid** 0.94 191 6.24 1.66 10.33 2.96 
        
 Day 2       
1 Fumaric Acid* 1.00 115 0.0504 0.0316 0.0167 0.0165 
2 Creatinine** 0.80 114 4.24 0.38 10.42 1.89 
3 Lysine** 0.62 147 0.051 0.027 0.182 0.087 
4 Citric Acid 0.94 191 6.68 1.04 5.39 3.09 
        
 Day 3       
1 Fumaric Acid** 1.00 115 0.0345 0.0303 0.1690 0.0912 
2 Creatinine** 0.80 114 4.02 1.16 10.10 3.02 
3 Lysine 0.62 147 0.112 0.104 0.113 0.092 
4 Citric Acid** 0.94 191 4.61 1.92 26.42 12.61 
        
 Day 4       
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1 Fumaric Acid 1.00 115 0.0392 0.0245 0.0413 0.0247 
2 Creatinine** 0.80 114 4.68 1.24 9.55 2.00 
3 Lysine* 0.62 147 0.074 0.056 0.158 0.075 
4 Citric Acid 0.94 191 6.74 1.81 8.08 10.17 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as 
mean ± SD (standard deviation). The statistics are as follows: significance difference between the control group 
(n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
Table 4.2 Selected Metabolites identified in rat urine samples for both the control group and treatment group as measured by LC/MS (positive 
and negative mode).
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Figure 4.12 and Figure 4.13 also show changes of selected metabolites as 
measured by LC/MS with positive and negative modes on different days. It can be 
seen from Figure 4.12 that the concentration of hypoxanthine, xanthine, uric acid, 
guanine and N1-methyladenosine increased for the treatment group. Figure 4.13 
illustrates that the fatty acids of the treatment group including adipic acid, lauric 
acid, palmitoleic acid, linoleic acid, furmaric acid and citrate increased. In 
addition, adipic acid, lauric acid, furmaric acid and citrate could recover from the 

















































































Figure 4.12 Changes of selected metabolites as measured by LC/MS (positive 
mode) on different days (Pink colour: control group, n=8, blue colour: treatment 
Chapter 4 Metabolic Profiling of Berberine in Rats with GC/MS, LC/MS and 1H NMR Spectroscopy 
127  
group, n=8). 







































































































(E)                                 (F) 
Figure 4.13 Changes of selected metabolites as measured by LC/MS (negative 
mode) on different days (Pink colour: control group, n=8, blue colour: treatment 
group, n=8). (A) adipic acid, (B) lauric acid, (C) palmitoleic acid, (D) linoleic acid, 
(E) furmaric acid and (F) citrate. 
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After data normalization, the multivariate statistical method PCA was carried out. 
The PCA scores plot showed that the two groups were scattered into two different 




Figure 4.14 Multivariate data analysis of LC/MS data (positive mode) metabolic 
profiles. 
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control at day 0, black circle control at day 1, Black diamond: control at day 2, 
Red triangle: treated at day 1, Blue triangle: treated at day 2) (R2X[1] = 0.177, 
R2X[2]= 0.128). 
(B) PCA scores plot for data from all rat urine samples collected (black triangle: 
control at day 3, black circle control at day 4, Red triangle: treated at day 3, Blue 
triangle: treated at day 4) (R2X[1] = 0.209, R2X[2]= 0.140). 
 
4.3.2 Discussion 
All the analyses performed (GC/MS of liver extracts, LC/MS of urine sample and 
1H NMR of urine samples) revealed substantial berberine-induced changes and a 
high degree of recovery by the end of the study. 
One important aim of this study is to investigate the metabolic response revealed 
by biomarkers after berberine adiministration by metabonomic approach. It has 
been reported that liver might be the metabolic site for berberine. GC/MS data of 
the lipid fraction of the liver extracts revealed that cholesterol, glucose, maltose 
and fatty acids decreased after the berberine exposure (Figure 4.5B). 
In this study, both LC/MS and 1H NMR were used to investigate the rat urinary 
metabolic profile associated with administration of berberine. The results obtained 
from both 1H NMR and LC/MS revealed the variations of certain metabolites in 
urinary composition. Therefore, it allowed us to obtain information about the 
mechanisms involved in metabolite excretion. For the current work, one of the 
challenges with GC/MS, LC/MS and 1HNMR was the analysis of the target 
metabolites in the presence of other peaks. Hence, peaks that had not been found 
in the control group were not included in the treatment group for data 
normalization purposes. 
From the results mentioned above, it can be seen that the changes in metabolite 
profiles observed by 1H NMR and LC/MS with pattern recognition tools were 
similar. However, the markers which indicated the separations of treatment group 
from control group observed were different. For example, betaine, taurine, 
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α-ketoglutarate, and glutamate were noticeable markers for 1H NMR, but due to 
either poor ionization abilities in ESI or poor elution/retention by LC, these 
compounds were not identified by LC/MS. On the other hand, markers such as 
pantothetic acids, riboflavin, and xanthurenic acid that were prominent 
compounds in LC/MS were not obvious for 1H NMR. Figure 4.11, Figure 4.12 
and Figure 4.13 show the changes of selected metabolites. 
In our earlier studies [52-53, 59], it has been found that using a multiple analytical 
approach not only provides additional information, but also enhances the 
confidence of the data obtained. In the current work, we used a targeted approach 
for the urine LC/MS data process. A non-targeted approach was applied to the 
processing of 1H NMR data. The results demonstrate that analysis of metabolites 
in rat urine samples from two different groups using with LC/MS (targeted) 
produced consistent and reliable results. Based on the targeted ions selected with 
LC/MS, the PCA score plots from different days were consistent with that 
obtained from using the non-targeted approach with 1H NMR where distinctive 
clusters are observed. Since berberine was administered on day1 and day3, the 
results on these two days could be interfered with the metabolites from berberine. 
As a result, the data from pre-dose, day2 and day4 were chosen for comparison. 
Both the data obtained from targeted and non-targeted processing on the pre-dose 
samples showed no significant changes. The results of day2 and day4 obtained by 
non-targeted processing of 1H NMR data showed the same changes with the 
results obtained by targeted processing of LC/MS data. The close agreement of 
results from 1H NMR and LC/MS on the change trends of selected metablotes in 
Table 4.1 and Table 4.2 proved the reliability and accuracy of the targeted data 
processing method. Finally, from Figure 4.9 and Figure 4.10 we can see that the 
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current approach allows us to study a number of metabolites present in 
carbohydrate metabolism, amino acid metabolism, TCA cycle, fatty acid 
metabolism, purine metabolism, metabolism and synthesis of major bile salts. 
4.4 Conclusion 
In this work, we develop a metabonomic approach based on GC/MS, LC/MS and 
1H NMR to elucidate the metabolic patterns induced by berberine in rat. Results 
obtained from GC/MS show that metabolites such as cholesterol, glucose, maltose 
and fatty acids were affected. The use of normalization to a constant sum for the 
LC/MS and 1H NMR with statistical analysis allowed for the identification of a 
network of potential biomarkers corresponding to the exposure of berberine. The 
close agreement of the results from targeted data processing of LC/MS and the 
results from non-targeted data processing of 1H NMR has proved the reliability 
and accuracy of the targeted data processing method. The proposed approach 
combined with pattern recognition tools such as PCA provided a more 
comprehensive picture of the metabolic changes induced by berberine in rat 
compared to any single analytical technique alone. The result obtained was 
information rich and provides a firm platform for future analysis. 
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Appendix for Chapter 4 
 
Metabolites identified in rat urine samples for both the control group and treatment group as measured by 
LCMS, pre-dose (positive mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time 
(min) 
m/z Control Ave ±SD Treated 
Ave 
±SD 
1 Stearamide 11.44 256 0.022 0.007 0.015 0.009 
2 Oleamide* 11.64 282 0.038 0.015 0.021 0.006 
3 Serine 0.79 118 0.825 0.436 0.949 0.289 
4 Homocysteine 0.85 132 0.057 0.035 0.125 0.077 
5 Lysine 0.62 147 0.038 0.018 0.059 0.029 
6 Phenylalanine 0.94 166 5.957 0.913 5.154 0.445 
7 Hypoxanthine 1.00 137 0.020 0.030 0.029 0.039 
8 Xanthine 0.76 151 0.493 0.310 0.235 0.061 
9 Uric Acid* 0.88 169 0.098 0.048 0.186 0.060 
10 Creatinine 0.80 114 6.091 1.082 5.559 1.102 
11 Kynurenic Acid 3.41 190 8.260 0.656 6.962 1.792 
12 Xanthurenic Acid 4.64 206 0.028 0.008 0.029 0.011 
13 Riboflavin 4.33 377 11.562 2.003 9.539 2.273 
14 Guanine 0.78 152 0.157 0.084 0.104 0.082 
15 Adenosine 1.01 268 2.180 0.533 1.896 0.232 
16 N1-Methyladenosine 0.89 282 2.240 0.278 1.969 0.219 
17 Guanosine 0.99 284 0.007 0.003 0.009 0.002 
18 N4-Acetylcytidine 1.06 286 0.134 0.144 0.199 0.235 
19 N2-Methylguanosine* 1.25 298 0.094 0.013 0.076 0.010 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as 
mean ± SD (standard deviation). The statistics are as follows: significance difference between the control group 
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(n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
(A) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by 
LCMS, day 1 (positive mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time 
(min) 
m/z Control Ave ±SD Treated 
Ave 
±SD 
1 Stearamide 11.44 256 0.028 0.008 0.046 0.023 
2 Oleamide 11.64 282 0.030 0.009 0.074 0.074 
3 Serine 0.79 118 0.995 0.197 1.093 0.335 
4 Homocysteine** 0.85 132 0.155 0.051 0.289 0.064 
5 Lysine 0.62 147 0.052 0.018 0.056 0.018 
6 Phenylalanine** 0.94 166 4.310 0.680 5.753 1.099 
7 Hypoxanthine 1.00 137 0.013 0.012 0.028 0.023 
8 Xanthine 0.76 151 0.181 0.096 0.173 0.037 
9 Uric Acid** 0.88 169 0.203 0.079 0.327 0.073 
10 Creatinine* 0.80 114 3.889 0.567 6.492 2.511 
11 Kynurenic Acid 3.41 190 10.408 1.414 10.904 2.797 
12 Xanthurenic Acid** 4.64 206 0.019 0.006 0.006 0.004 
13 Riboflavin** 4.33 377 6.118 1.538 2.159 1.073 
14 Guanine 0.78 152 0.095 0.082 0.106 0.048 
15 Adenosine* 1.01 268 1.717 0.328 1.369 0.171 
16 N1-Methyladenosine* 0.89 282 1.557 0.216 1.823 0.269 
17 Guanosine** 0.99 284 0.009 0.004 0.028 0.012 
18 N4-Acetylcytidine 1.06 286 0.171 0.140 0.200 0.133 
19 N2-Methylguanosine* 1.25 298 0.074 0.021 0.053 0.006 
The relative intensity of metabolites is expressed with their normalized peak area.Values are represented as 
mean ± SD (standard deviation). The statistics are as follows: significance difference between the control group 
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(n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
(B) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by 
LCMS, day 2 (positive mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time 
(min) 
m/z Control Ave ±SD Treated 
Ave 
±SD 
1 Stearamide 11.44 256 0.035 0.009 0.084 0.085 
2 Oleamide 11.64 282 0.086 0.126 0.499 1.226 
3 Serine 0.79 118 1.015 0.341 2.803 2.393 
4 Homocysteine 0.85 132 0.143 0.080 0.743 1.205 
5 Lysine** 0.62 147 0.051 0.027 0.182 0.087 
6 Phenylalanine** 0.94 166 4.139 0.418 5.815 0.933 
7 Hypoxanthine 1.00 137 0.434 1.203 0.099 0.175 
8 Xanthine* 0.76 151 0.149 0.045 0.311 0.154 
9 Uric Acid 0.88 169 0.137 0.037 0.647 0.740 
10 Creatinine** 0.80 114 4.240 0.386 10.426 1.892 
11 Kynurenic Acid 3.41 190 10.826 1.401 9.627 3.712 
12 Xanthurenic Acid 4.64 206 0.019 0.008 0.012 0.009 
13 Riboflavin 4.33 377 4.448 1.871 2.985 1.279 
14 Guanine 0.78 152 0.125 0.069 0.145 0.063 
15 Adenosine 1.01 268 1.945 0.102 1.845 0.429 
16 N1-Methyladenosine** 0.89 282 1.390 0.082 1.944 0.326 
17 Guanosine 0.99 284 0.017 0.008 0.011 0.007 
18 N4-Acetylcytidine** 1.06 286 0.291 0.063 0.132 0.041 
19 N2-Methylguanosine 1.25 298 0.067 0.025 0.091 0.032 
The relative intensity of metabolites is expressed with their normalized peak area.Values are represented as 
mean ± SD (standard deviation). The statistics are as follows: significance difference between the control group 
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(n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
(C) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by 
LCMS, day 3 (positive mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time 
(min) 
m/z Control Ave ±SD Treated 
Ave 
±SD 
1 Stearamide** 11.44 256 0.046 0.023 0.090 0.032 
2 Oleamide 11.64 282 0.069 0.055 0.090 0.023 
3 Serine 0.79 118 1.199 0.739 3.702 3.552 
4 Homocysteine 0.85 132 0.127 0.081 29.233 42.377 
5 Lysine 0.62 147 0.112 0.104 0.113 0.092 
6 Phenylalanine 0.94 166 4.072 1.012 5.837 2.287 
7 Hypoxanthine** 1.00 137 0.011 0.014 0.331 0.240 
8 Xanthine 0.76 151 0.130 0.029 0.329 0.480 
9 Uric Acid** 0.88 169 0.173 0.073 0.528 0.318 
10 Creatinine** 0.80 114 4.025 1.167 10.101 3.025 
11 Kynurenic Acid 3.41 190 10.496 1.859 11.865 4.267 
12 Xanthurenic Acid 4.64 206 0.019 0.010 0.013 0.011 
13 Riboflavin** 4.33 377 4.885 1.557 1.920 1.099 
14 Guanine* 0.78 152 0.102 0.071 0.246 0.128 
15 Adenosine 1.01 268 1.677 0.465 1.890 1.014 
16 N1-Methyladenosine 0.89 282 1.466 0.293 1.642 0.558 
17 Guanosine* 0.99 284 0.014 0.010 0.029 0.011 
18 N4-Acetylcytidine 1.06 286 0.290 0.084 0.248 0.194 
19 N2-Methylguanosine 1.25 298 0.062 0.015 0.044 0.020 
The relative intensity of metabolites is expressed with their normalized peak area.Values are represented as 
mean ± SD (standard deviation). The statistics are as follows: significance difference between the control group 
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(n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
(D) 
Chapter 4 Metabolic Profiling of Berberine in Rats with GC/MS, LC/MS and 1H NMR Spectroscopy 
145  
 
Metabolites identified in rat urine samples for both the control group and treatment group as measured by 
LCMS, day 4 (positive mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time 
(min) 
m/z Control Ave ±SD Treated 
Ave 
±SD 
1 Stearamide* 11.44 256 0.026 0.010 0.049 0.028 
2 Oleamide** 11.64 282 0.027 0.005 0.061 0.025 
3 Serine** 0.79 118 1.155 0.596 3.282 1.306 
4 Homocysteine* 0.85 132 0.172 0.176 10.492 12.370 
5 Lysine* 0.62 147 0.074 0.056 0.158 0.075 
6 Phenylalanine** 0.94 166 3.831 0.982 5.523 1.247 
7 Hypoxanthine* 1.00 137 0.010 0.008 0.130 0.135 
8 Xanthine 0.76 151 0.130 0.020 0.430 0.617 
9 Uric Acid** 0.88 169 0.182 0.065 0.553 0.222 
10 Creatinine** 0.80 114 4.687 1.242 9.556 2.006 
11 Kynurenic Acid 3.41 190 7.665 1.432 7.960 2.975 
12 Xanthurenic Acid 4.64 206 0.019 0.012 0.014 0.013 
13 Riboflavin 4.33 377 4.109 0.888 2.564 2.549 
14 Guanine** 0.78 152 0.109 0.069 0.352 0.120 
15 Adenosine 1.01 268 1.934 0.519 2.258 0.730 
16 N1-Methyladenosine* 0.89 282 1.327 0.183 1.761 0.427 
17 Guanosine 0.99 284 0.011 0.007 0.019 0.013 
18 N4-Acetylcytidine 1.06 286 0.236 0.184 0.117 0.045 
19 N2-Methylguanosine 1.25 298 0.076 0.023 0.081 0.033 
The relative intensity of metabolites is expressed with their normalized peak area.Values are represented as 
mean ± SD (standard deviation). The statistics are as follows: significance difference between the control group 
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(n=8) and treatment group (n=8) is based on two tailed student t test (* p<0.05, ** p<0.01). 
(E) 
Table 4.3 Metabolites identified in rat urine samples for both the control group and treatment group as measured by LC-MS (positive mode). 
(A) Pre-dose, (B) Day 1, (C) Day 2 (D) Day 3 and (E) Day 4.
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by LCMS, pre-dose (negative mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time (min) m/z Control Ave ±SD Treated Ave ±SD 
1 Fumaric Acid 1.00 115 0.0227 0.0118 0.0312 0.0228 
2 Adipic Acid 2.34 145 0.4166 0.1802 0.4438 0.4703 
3 Lauric Acid 9.92 199 0.0065 0.0043 0.0083 0.0058 
4 Mystric Acid 9.95 227 0.0020 0.0030 0.0049 0.0024 
5 Palmitoleic Acid 11.05 253 0.0035 0.0016 0.0109 0.0104 
6 γ-Linoleic Acid 10.79 277 0.0011 0.0007 0.0025 0.0034 
7 Linoleic Acid 11.20 279 0.0132 0.0044 0.0155 0.0090 
8 Oleic Acid* 6.31 281 0.0236 0.0116 0.0735 0.0408 
9 Decosahexaenoic Acid (DHA) 11.01 327 0.0024 0.0017 0.0024 0.0021 
10 Deoxycholic Acid (DCA) 8.79 391 0.0045 0.0071 0.0042 0.0029 
11 Cholic Acid (CA) 7.51 407 0.3680 0.3719 0.2860 0.3231 
12 Glycodeoxycholic Acid(GDCA) 7.80 448 0.0014 0.0011 0.0022 0.0020 
13 Glycocholic Acid (GCA) 6.82 464 0.0281 0.0435 0.0116 0.0079 
14 Tauroursdeoxycholic Acid (TUDCA) 6.16 498 0.0027 0.0021 0.0040 0.0033 
15 Taurochenodeoxycholic Acid (TCDCA)* 6.62 498 0.0026 0.0014 0.0009 0.0006 
16 Taurodeoxycholic Acid (TDCA) 6.72 498 0.0027 0.0021 0.0021 0.0019 
17 Taurocholic Acid (TCA) 6.21 514 0.0407 0.0208 0.0402 0.0283 
18 Phenol Sulphate 2.09 173 63.0481 10.4543 62.2522 10.6504 
19 Resorcinol Sulphate 1.81 189 25.5235 7.9718 26.0519 7.9606 
20 Citric Acid 0.94 191 6.1097 1.5170 5.9763 1.7126 
21 Sebacic Acid 5.92 201 4.3768 1.1372 4.7756 1.0962 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ± SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student 
t test (* p<0.05, ** p<0.01). 
(A) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by LCMS, day 1 (negative mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time (min) m/z Control Ave ±SD Treated Ave ±SD 
1 Fumaric Acid 1.00 115 0.0247 0.0071 0.0247 0.0170 
2 Adipic Acid** 2.34 145 0.9176 0.2861 2.8841 1.6902 
3 Lauric Acid 9.92 199 0.0178 0.0161 0.0147 0.0080 
4 Mystric Acid 9.95 227 0.0042 0.0032 0.0102 0.0102 
5 Palmitoleic Acid 11.05 253 0.0065 0.0034 0.0114 0.0070 
6 γ-Linoleic Acid 10.79 277 0.0025 0.0014 0.0041 0.0045 
7 Linoleic Acid 11.20 279 0.0163 0.0090 0.0339 0.0291 
8 Oleic Acid 6.31 281 0.1290 0.0692 0.1034 0.0930 
9 Decosahexaenoic Acid (DHA)** 11.01 327 0.0024 0.0017 0.0083 0.0043 
10 Deoxycholic Acid (DCA)** 8.79 391 0.0034 0.0028 0.0092 0.0034 
11 Cholic Acid (CA)** 7.51 407 0.6888 0.2848 0.0987 0.0636 
12 Glycodeoxycholic Acid(GDCA) 7.80 448 0.0023 0.0021 0.0023 0.0030 
13 Glycocholic Acid (GCA)* 6.82 464 0.0289 0.0237 0.0075 0.0073 
14 Tauroursdeoxycholic Acid (TUDCA) 6.16 498 0.0088 0.0068 0.0109 0.0089 
15 Taurochenodeoxycholic Acid (TCDCA) 6.62 498 0.0029 0.0026 0.0044 0.0036 
16 Taurodeoxycholic Acid (TDCA) 6.72 498 0.0021 0.0013 0.0045 0.0068 
17 Taurocholic Acid (TCA) 6.21 514 0.0114 0.0116 0.0096 0.0062 
18 Phenol Sulphate 2.09 173 56.0683 7.3503 46.6392 11.4806 
19 Resorcinol Sulphate 1.81 189 29.1860 6.7124 35.4629 8.3315 
20 Citric Acid** 0.94 191 6.2478 1.6675 10.3336 2.9629 
21 Sebacic Acid 5.92 201 6.6282 2.9841 4.3224 2.0137 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ± SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student 
t test (* p<0.05, ** p<0.01). 
(B) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by LCMS, day 2 (negative mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time (min) m/z Control Ave ±SD Treated Ave ±SD 
1 Fumaric Acid* 1.00 115 0.0504 0.0316 0.0167 0.0165 
2 Adipic Acid* 2.34 145 0.9271 0.1963 3.3375 3.0076 
3 Lauric Acid 9.92 199 0.0169 0.0189 0.0393 0.0286 
4 Mystric Acid 9.95 227 0.0061 0.0025 0.0096 0.0082 
5 Palmitoleic Acid 11.05 253 0.0205 0.0367 0.0361 0.0483 
6 γ-Linoleic Acid 10.79 277 0.0030 0.0018 0.0023 0.0018 
7 Linoleic Acid* 11.20 279 0.0121 0.0079 0.0360 0.0269 
8 Oleic Acid 6.31 281 0.1524 0.0745 0.1445 0.1306 
9 Decosahexaenoic Acid (DHA)* 11.01 327 0.0032 0.0033 0.0096 0.0075 
10 Deoxycholic Acid (DCA)* 8.79 391 0.0034 0.0035 0.0151 0.0133 
11 Cholic Acid (CA) 7.51 407 0.6240 0.3219 0.6345 0.7700 
12 Glycodeoxycholic Acid(GDCA) 7.80 448 0.0013 0.0015 0.0021 0.0025 
13 Glycocholic Acid (GCA) 6.82 464 0.0157 0.0086 0.0181 0.0189 
14 Tauroursdeoxycholic Acid (TUDCA) 6.16 498 0.0060 0.0034 0.0096 0.0088 
15 Taurochenodeoxycholic Acid (TCDCA) 6.62 498 0.0041 0.0035 0.0089 0.0103 
16 Taurodeoxycholic Acid (TDCA) 6.72 498 0.0036 0.0022 0.0080 0.0070 
17 Taurocholic Acid (TCA) 6.21 514 0.0098 0.0068 0.0230 0.0178 
18 Phenol Sulphate 2.09 173 49.0436 9.2321 46.0537 13.4921 
19 Resorcinol Sulphate* 1.81 189 35.3092 8.2934 25.8835 8.2143 
20 Citric Acid 0.94 191 6.9364 1.2124 4.7452 3.3889 
21 Sebacic Acid 5.92 201 6.8511 2.1696 18.9666 16.9646 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ± SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(C) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by LCMS, day 3 (negative mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time (min) m/z Control Ave ±SD Treated Ave ±SD 
1 Fumaric Acid** 1.00 115 0.0345 0.0303 0.1690 0.0912 
2 Adipic Acid** 2.34 145 1.1230 0.3561 13.5351 10.9277 
3 Lauric Acid** 9.92 199 0.0215 0.0106 0.0605 0.0280 
4 Mystric Acid 9.95 227 0.0059 0.0041 0.0160 0.0137 
5 Palmitoleic Acid* 11.05 253 0.0065 0.0040 0.0349 0.0293 
6 γ-Linoleic Acid 10.79 277 0.0018 0.0008 0.0039 0.0036 
7 Linoleic Acid 11.20 279 0.0219 0.0177 0.0463 0.0453 
8 Oleic Acid** 6.31 281 0.0178 0.0132 0.2163 0.1773 
9 Decosahexaenoic Acid (DHA) 11.01 327 0.0052 0.0041 0.0265 0.0338 
10 Deoxycholic Acid (DCA) 8.79 391 0.0052 0.0050 0.0607 0.0903 
11 Cholic Acid (CA) 7.51 407 0.3782 0.1937 2.8123 5.3944 
12 Glycodeoxycholic Acid(GDCA) 7.80 448 0.0034 0.0050 0.0070 0.0136 
13 Glycocholic Acid (GCA) 6.82 464 0.0090 0.0076 0.0127 0.0114 
14 Tauroursdeoxycholic Acid (TUDCA) 6.16 498 0.0069 0.0063 0.0086 0.0040 
15 Taurochenodeoxycholic Acid (TCDCA) 6.62 498 0.0046 0.0043 0.0122 0.0125 
16 Taurodeoxycholic Acid (TDCA)* 6.72 498 0.0023 0.0019 0.0071 0.0048 
17 Taurocholic Acid (TCA) 6.21 514 0.0087 0.0055 0.1294 0.2408 
18 Phenol Sulphate** 2.09 173 51.8815 9.2533 28.6927 12.3776 
19 Resorcinol Sulphate** 1.81 189 33.9433 8.9576 19.1343 7.4234 
20 Citric Acid** 0.94 191 4.6160 1.9202 26.4212 12.6128 
21 Sebacic Acid 5.92 201 7.9030 2.9628 8.5933 9.4349 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ± SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(D) 
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Metabolites identified in rat urine samples for both the control group and treatment group as measured by LCMS, day 4 (negative mode) 
 Normalized peak intensitya (%) 
NO. Metabolite Retention Time (min) m/z Control Ave ±SD Treated Ave ±SD 
1 Fumaric Acid 1.00 115 0.0392 0.0245 0.0413 0.0247 
2 Adipic Acid* 2.34 145 0.9119 0.3779 4.1145 3.6067 
3 Lauric Acid 9.92 199 0.0189 0.0150 0.0269 0.0209 
4 Mystric Acid* 9.95 227 0.0043 0.0019 0.0141 0.0114 
5 Palmitoleic Acid* 11.05 253 0.0039 0.0013 0.0287 0.0282 
6 γ-Linoleic Acid 10.79 277 0.0032 0.0030 0.0060 0.0055 
7 Linoleic Acid 11.20 279 0.0319 0.0246 0.0770 0.0641 
8 Oleic Acid 6.31 281 0.1229 0.1030 0.4016 0.7211 
9 Decosahexaenoic Acid (DHA) 11.01 327 0.0043 0.0035 0.0067 0.0045 
10 Deoxycholic Acid (DCA)* 8.79 391 0.0035 0.0017 0.0099 0.0075 
11 Cholic Acid (CA) 7.51 407 0.3641 0.3192 0.8373 0.6912 
12 Glycodeoxycholic Acid(GDCA) 7.80 448 0.0025 0.0032 0.0005 0.0006 
13 Glycocholic Acid (GCA) 6.82 464 0.0111 0.0103 0.0238 0.0304 
14 Tauroursdeoxycholic Acid (TUDCA) 6.16 498 0.0056 0.0045 0.0061 0.0068 
15 Taurochenodeoxycholic Acid (TCDCA) 6.62 498 0.0042 0.0021 0.0172 0.0351 
16 Taurodeoxycholic Acid (TDCA) 6.72 498 0.0029 0.0013 0.0189 0.0361 
17 Taurocholic Acid (TCA)* 6.21 514 0.0058 0.0026 0.0364 0.0342 
18 Phenol Sulphate 2.09 173 48.9471 5.3559 41.2996 12.3225 
19 Resorcinol Sulphate 1.81 189 34.7741 3.1317 29.4535 11.3337 
20 Citric Acid 0.94 191 6.7468 1.8129 8.0855 10.1793 
21 Sebacic Acid* 5.92 201 7.9918 4.8422 15.4946 8.3890 
The relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ± SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(E) 
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Table 4.4 Metabolites identified in rat urine samples for both the control group and treatment group as measured by LC-MS (negative mode). 
(A) Pre-dose, (B) Day 1, (C) Day 2, (D) Day 3 and (E) Day 4.
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Metabolites identified in rat urine samples for both control and treatment group as measured by 1H NMR, pre-dose 
 Normalized peak intensitya 
NO. Metabolite Chemical Shift (ppm) Multiplicity Control Ave ±SD Treated Ave ±SD 
1 Tryptamine 7.69 d 0.26 0.03 0.31 0.20 
 Tryptamine 7.32 d 0.31 0.03 0.32 0.08 
 Tryptamine * 7.24 d 0.17 0.02 0.21 0.04 
2 Hippurate 7.62 t 0.50 0.15 0.39 0.27 
 Hippurate 7.55 t 1.73 0.55 1.63 0.74 
3 Phenylacetylglycine 7.40 m 0.83 0.31 0.52 0.30 
 Phenylacetylglycine 7.36 m 1.36 0.47 1.08 0.24 
4 Tyrosine 7.16 m 0.28 0.10 0.23 0.07 
 Tyrosine 6.87 m 0.34 0.10 0.26 0.04 
5 Fumurate 6.53 s 0.18 0.04 0.17 0.04 
6 Creatine 3.91 s 0.24 0.03 0.25 0.03 
7 Creatinine 3.08 s 0.15 0.03 0.15 0.07 
8 Betaine 3.88 s 0.42 0.09 0.45 0.07 
9 Glucose 3.83 m 0.33 0.03 0.36 0.06 
 Glucose 3.66 m 0.56 0.04 0.51 0.35 
 Glucose 3.51 m 0.39 0.05 0.39 0.03 
10 Methionine 3.76 m 0.54 0.27 0.73 0.26 
 Methionine 2.14 m 0.51 0.04 0.57 0.07 
 Methionine 2.13 s 0.42 0.04 0.46 0.06 
11 Lysine 3.74 t 0.41 0.21 0.38 0.26 
12 Ethanol 3.64 q 0.73 0.12 0.66 0.30 
13 Glycine 3.52 s 0.37 0.07 0.37 0.06 
14 Taurine 3.41 t 0.33 0.03 1.02 1.40 
 Taurine 3.18 t 0.25 0.04 0.24 0.05 
15 Hypotaurine 3.35 t 0.19 0.06 0.22 0.08 
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16 Trimethylamine –N-oxide (TMAO) 3.25 s 0.52 0.10 1.00 1.21 
17 Creatinine/Creatine 3.01 s 4.58 0.93 4.22 1.44 
18 α-Ketoglutarate 3.00 t 2.47 0.39 2.22 1.05 
 α-Ketoglutarate 2.43 t 2.22 0.63 2.55 0.96 
19 Dimethylglycine 2.93 s 1.55 0.39 1.24 0.65 
20 Trimethylamine (TMA) 2.85 s 0.25 0.11 0.20 0.09 
21 Aspartic Acid 2.84 m 0.40 0.22 0.29 0.05 
22 Citrate 2.62 d 0.28 0.04 0.32 0.04 
 Citrate 2.60 d 0.24 0.06 0.23 0.14 
 Citrate 2.60 d 0.32 0.05 0.34 0.06 
 Citrate 2.50 d 0.37 0.07 0.32 0.08 
23 Glutamine 2.44 m 4.17 1.80 3.74 2.62 
24 Succinate 2.42 s 0.77 0.17 1.76 2.50 
25 Pyruvate 2.39 s 0.52 0.12 0.52 0.08 
26 Glutamate 2.36 m 0.44 0.06 0.43 0.07 
 Glutamate 2.33 m 0.60 0.07 0.64 0.15 
27 Acetoacetate 2.27 s 0.37 0.06 0.37 0.08 
28 Arginine 1.63 m 0.30 0.03 0.32 0.05 
29 Alanine 1.49 d 0.42 0.07 0.45 0.08 
 Alanine 1.47 d 0.44 0.06 0.42 0.11 
30 Lactate* 1.34 d 0.42 0.08 0.62 0.15 
 Lactate 1.32 d 0.38 0.05 0.48 0.14 
31 3-D-Hydroxybutyrate 1.20 d 0.48 0.08 0.48 0.08 
32 Isobutyrate 1.11 d 0.15 0.04 0.15 0.05 
33 Valine 1.04 d 0.14 0.03 0.15 0.04 
 Valine 0.98 d 0.14 0.02 0.14 0.03 
34 Leucine 1.00 m 0.14 0.02 0.15 0.03 
 Leucine 0.94 m 0.43 0.22 0.70 0.49 
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aThe relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ±SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(A)
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Metabolites identified in rat urine samples for both control and treatment group as measured by 1H NMR, day 1 
 Normalized peak intensitya 
NO. Metabolite Chemical Shift (ppm) Multiplicity Control Ave ±SD Treated Ave ±SD 
1 Tryptamine* 7.69 d 0.15 0.07 0.04 0.09 
 Tryptamine* 7.32 d 0.30 0.07 0.20 0.10 
 Tryptamine 7.24 d 0.23 0.06 0.13 0.15 
2 Hippurate 7.62 t 0.43 0.10 0.37 0.08 
 Hippurate 7.55 t 1.51 0.36 1.23 0.27 
3 Phenylacetylglycine 7.40 m 0.46 0.11 0.39 0.17 
 Phenylacetylglycine * 7.36 m 0.74 0.21 0.47 0.25 
4 Tyrosine 7.16 m 0.30 0.08 0.18 0.12 
 Tyrosine ** 6.87 m 0.41 0.08 0.18 0.10 
5 Fumurate 6.53 s 0.26 0.03 0.23 0.09 
6 Creatine* 3.91 s 0.47 0.10 1.37 0.80 
7 Creatinine  3.08 s 0.21 0.03 0.17 0.06 
8 Betaine** 3.88 s 0.58 0.24 1.94 0.90 
9 Glucose** 3.83 m 0.58 0.09 2.14 1.11 
 Glucose 3.66 m 1.02 0.09 0.91 0.31 
 Glucose ** 3.51 m 0.63 0.09 2.17 1.07 
10 Methionine** 3.76 m 0.93 0.10 1.52 0.26 
 Methionine 2.14 m 0.46 0.04 0.45 0.15 
 Methionine 2.13 s 0.38 0.03 0.32 0.12 
11 Lysine 3.74 t 0.65 0.27 1.79 1.48 
12 Ethanol 3.64 q 1.26 0.12 1.12 0.40 
13 Glycine** 3.52 s 0.61 0.07 1.59 0.71 
14 Taurine** 3.41 t 2.43 1.47 6.05 2.01 
 Taurine * 3.18 t 0.35 0.04 0.23 0.10 
15 Hypotaurine 3.35 t 0.43 0.12 0.37 0.07 
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16 Trimethylamine –N-oxide (TMAO)** 3.25 s 2.55 0.84 5.79 1.79 
17 Creatinine/Creatine** 3.01 s 4.13 1.30 1.23 0.76 
18 α-Ketoglutarate** 3.00 t 2.41 0.73 0.83 0.42 
 α-Ketoglutarate ** 2.43 t 1.95 0.58 0.70 0.38 
19 Dimethylglycine** 2.93 s 1.54 0.39 0.30 0.23 
20 Trimethylamine (TMA)** 2.85 s 0.29 0.04 0.14 0.07 
21 Aspartic Acid** 2.84 m 0.49 0.09 0.22 0.11 
22 Citrate 2.62 d 0.28 0.02 0.28 0.11 
 Citrate 2.60 d 0.20 0.13 0.15 0.15 
 Citrate 2.60 d 0.34 0.04 0.28 0.08 
 Citrate 2.50 d 0.41 0.09 0.49 0.38 
23 Glutamine** 2.44 m 3.61 1.14 1.17 0.71 
24 Succinate** 2.42 s 0.89 0.07 0.46 0.31 
25 Pyruvate 2.39 s 0.51 0.10 0.43 0.16 
26 Glutamate 2.36 m 0.23 0.20 0.28 0.14 
 Glutamate ** 2.33 m 0.56 0.04 0.36 0.14 
27 Acetoacetate 2.27 s 0.30 0.04 0.24 0.10 
28 Arginine 1.63 m 0.25 0.04 0.20 0.08 
29 Alanine 1.49 d 0.27 0.04 0.23 0.07 
 Alanine 1.47 d 0.28 0.04 0.24 0.08 
30 Lactate 1.34 d 0.37 0.03 0.40 0.10 
 Lactate 1.32 d 0.33 0.03 0.38 0.10 
31 3-D-Hydroxybutyrate 1.20 d 0.27 0.11 0.21 0.15 
32 Isobutyrate 1.11 d 0.09 0.05 0.07 0.05 
33 Valine 1.04 d 0.10 0.04 0.09 0.04 
 Valine 0.98 d 0.11 0.03 0.10 0.04 
34 Leucine 1.00 m 0.10 0.03 0.09 0.04 
 Leucine** 0.94 m 0.32 0.03 0.23 0.08 
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aThe relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ±SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(B)
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 Metabolites identified in rat urine samples for both control and treatment groups as measured by 1H NMR, day 2 
 Normalized peak intensitya 
NO. Metabolite Chemical Shift (ppm) Multiplicity Control Ave ±SD Treated Ave ±SD 
1 Tryptamine 7.69 d 0.12 0.06 0.16 0.07 
 Tryptamine 7.32 d 0.23 0.07 0.17 0.08 
 Tryptamine 7.24 d 0.21 0.06 0.15 0.05 
2 Hippurate* 7.62 t 0.48 0.09 0.29 0.19 
 Hippurate * 7.55 t 1.67 0.33 1.02 0.55 
3 Phenylacetylglycine* 7.40 m 0.34 0.08 0.49 0.12 
 Phenylacetylglycine 7.36 m 0.52 0.12 0.66 0.22 
4 Tyrosine 7.16 m 0.24 0.06 0.20 0.04 
 Tyrosine ** 6.87 m 0.36 0.12 0.21 0.06 
5 Fumurate** 6.53 s 0.27 0.02 0.13 0.06 
6 Creatine 3.91 s 0.37 0.07 0.41 0.06 
7 Creatinine** 3.08 s 0.19 0.03 0.33 0.04 
8 Betaine 3.88 s 0.56 0.07 0.49 0.06 
9 Glucose** 3.83 m 0.50 0.07 0.64 0.05 
 Glucose 3.66 m 0.83 0.09 0.99 0.24 
 Glucose * 3.51 m 0.54 0.09 0.67 0.05 
10 Methionine 3.76 m 0.75 0.10 0.82 0.35 
 Methionine ** 2.14 m 0.38 0.04 0.63 0.09 
 Methionine ** 2.13 s 0.33 0.04 0.57 0.06 
11 Lysine** 3.74 t 0.71 0.10 1.08 0.19 
12 Ethanol** 3.64 q 1.04 0.08 1.22 0.06 
13 Glycine* 3.52 s 0.51 0.07 0.59 0.04 
14 Taurine 3.41 t 3.89 1.16 3.06 1.49 
 Taurine * 3.18 t 0.35 0.05 0.42 0.06 
15 Hypotaurine 3.35 t 0.34 0.11 0.37 0.10 
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16 Trimethylamine –N-oxide (TMAO) 3.25 s 3.19 0.94 3.54 4.14 
17 Creatinine/Creatine** 3.01 s 4.28 1.27 1.58 0.73 
18 α-Ketoglutarate* 3.00 t 2.40 0.67 1.03 0.95 
 α-Ketoglutarate * 2.43 t 1.99 0.53 1.09 0.87 
19 Dimethylglycine 2.93 s 1.78 0.56 1.61 0.98 
20 Trimethylamine (TMA) 2.85 s 0.30 0.16 0.21 0.03 
21 Aspartic Acid 2.84 m 0.52 0.30 0.28 0.07 
22 Citrate 2.62 d 0.30 0.05 0.19 0.12 
 Citrate 2.60 d 0.27 0.08 0.24 0.03 
 Citrate 2.60 d 0.28 0.12 0.32 0.08 
 Citrate 2.50 d 0.36 0.09 0.41 0.03 
23 Glutamine** 2.44 m 3.86 1.12 1.34 0.84 
24 Succinate 2.42 s 0.84 0.08 0.81 0.16 
25 Pyruvate 2.39 s 0.44 0.08 1.01 1.18 
26 Glutamate* 2.36 m 0.30 0.13 0.48 0.10 
 Glutamate ** 2.33 m 0.49 0.06 0.71 0.09 
27 Acetoacetate* 2.27 s 0.31 0.05 0.36 0.02 
28 Arginine** 1.63 m 0.22 0.04 0.33 0.03 
29 Alanine** 1.49 d 0.23 0.04 0.35 0.08 
 Alanine ** 1.47 d 0.25 0.04 0.39 0.05 
30 Lactate** 1.34 d 0.34 0.06 0.55 0.17 
 Lactate ** 1.32 d 0.29 0.05 0.61 0.10 
31 3-D-Hydroxybutyrate** 1.20 d 0.24 0.11 0.36 0.09 
32 Isobutyrate 1.11 d 0.09 0.05 0.14 0.05 
33 Valine 1.04 d 0.09 0.04 0.13 0.03 
 Valine * 0.98 d 0.09 0.03 0.14 0.03 
34 Leucine 1.00 m 0.08 0.04 0.13 0.03 
 Leucine ** 0.94 m 0.31 0.04 0.47 0.14 
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aThe relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ±SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(C)
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Metabolites identified in rat urine samples for both control and treatment groups as measured by 1H NMR, day 3 
 Normalized peak intensitya 
NO. Metabolite Chemical Shift (ppm) Multiplicity Control Ave ±SD Treated Ave ±SD 
1 Tryptamine 7.69 d 0.08 0.03 0.04 0.03 
 Tryptamine ** 7.32 d 0.22 0.03 0.07 0.06 
 Tryptamine ** 7.24 d 0.15 0.02 0.04 0.04 
2 Hippurate** 7.62 t 0.52 0.17 0.04 0.04 
 Hippurate ** 7.55 t 1.79 0.57 0.16 0.14 
3 Phenylacetylglycine 7.40 m 0.30 0.09 0.26 0.23 
 Phenylacetylglycine 7.36 m 0.49 0.14 0.30 0.29 
4 Tyrosine 7.16 m 0.17 0.03 0.09 0.09 
 Tyrosine * 6.87 m 0.24 0.04 0.12 0.11 
5 Fumurate 6.53 s 0.20 0.03 0.31 0.33 
6 Creatine* 3.91 s 0.43 0.06 1.43 1.15 
7 Creatinine* 3.08 s 0.25 0.03 0.13 0.12 
8 Betaine 3.88 s 0.65 0.14 1.79 1.48 
9 Glucose* 3.83 m 0.65 0.08 2.04 1.66 
 Glucose * 3.66 m 0.99 0.13 0.53 0.35 
 Glucose * 3.51 m 0.63 0.10 2.40 1.97 
10 Methionine 3.76 m 0.96 0.13 1.34 0.77 
 Methionine * 2.14 m 0.45 0.06 0.27 0.20 
 Methionine * 2.13 s 0.35 0.05 0.19 0.14 
11 Lysine* 3.74 t 0.91 0.11 2.58 1.94 
12 Ethanol* 3.64 q 1.10 0.17 0.67 0.45 
13 Glycine* 3.52 s 0.60 0.09 1.80 1.41 
14 Taurine 3.41 t 4.81 1.25 6.11 4.22 
 Taurine ** 3.18 t 0.37 0.06 0.15 0.14 
15 Hypotaurine 3.35 t 0.39 0.15 0.23 0.12 
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16 Trimethylamine –N-oxide (TMAO) 3.25 s 3.48 1.66 4.75 2.91 
17 Creatinine/Creatine* 3.01 s 3.53 1.62 1.37 1.53 
18 α-Ketoglutarate* 3.00 t 1.97 0.88 0.72 0.84 
 α-Ketoglutarate 2.43 t 1.58 0.66 0.82 0.71 
19 Dimethylglycine** 2.93 s 1.95 0.57 0.39 0.36 
20 Trimethylamine (TMA)** 2.85 s 0.22 0.03 0.06 0.09 
21 Aspartic Acid** 2.84 m 0.34 0.05 0.09 0.12 
22 Citrate** 2.62 d 0.26 0.07 0.10 0.08 
 Citrate ** 2.60 d 0.27 0.07 0.12 0.10 
 Citrate 2.60 d 0.32 0.13 0.15 0.13 
 Citrate 2.50 d 0.30 0.05 0.17 0.16 
23 Glutamine* 2.44 m 3.04 1.37 1.26 1.37 
24 Succinate* 2.42 s 0.78 0.11 0.49 0.34 
25 Pyruvate 2.39 s 0.41 0.06 0.56 0.58 
26 Glutamate 2.36 m 0.32 0.04 0.56 0.34 
 Glutamate 2.33 m 0.50 0.07 0.59 0.60 
27 Acetoacetate* 2.27 s 0.25 0.04 0.12 0.12 
28 Arginine** 1.63 m 0.18 0.02 0.08 0.07 
29 Alanine 1.49 d 0.21 0.04 0.20 0.14 
 Alanine 1.47 d 0.22 0.04 0.21 0.14 
30 Lactate 1.34 d 0.35 0.04 7.09 10.11 
 Lactate 1.32 d 0.29 0.06 6.77 9.67 
31 3-D-Hydroxybutyrate 1.20 d 0.25 0.04 1.60 2.48 
32 Isobutyrate 1.11 d 0.04 0.01 0.03 0.05 
33 Valine 1.04 d 0.04 0.01 0.02 0.04 
 Valine 0.98 d 0.05 0.02 0.03 0.05 
34 Leucine 1.00 m 0.05 0.01 0.03 0.05 
 Leucine ** 0.94 m 0.35 0.03 0.16 0.11 
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aThe relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ±SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(D)
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Metabolites identified in rat urine samples for both control and treatment groups as measured by 1H NMR, day 4 
 Normalized peak intensitya 
NO. Metabolite Chemical Shift (ppm) Multiplicity Control Ave ±SD Treated Ave ±SD 
1 Tryptamine** 7.69 d 0.16 0.04 0.68 0.31 
 Tryptamine 7.32 d 0.23 0.07 0.21 0.07 
 Tryptamine 7.24 d 0.18 0.04 0.18 0.09 
2 Hippurate** 7.62 t 0.61 0.26 0.20 0.10 
 Hippurate ** 7.55 t 2.53 0.87 0.62 0.29 
3 Phenylacetylglycine* 7.40 m 0.30 0.07 0.77 0.52 
 Phenylacetylglycine 7.36 m 0.48 0.10 1.12 0.91 
4 Tyrosine 7.16 m 0.15 0.03 0.20 0.06 
 Tyrosine 6.87 m 0.19 0.07 0.26 0.04 
5 Fumurate 6.53 s 0.15 0.04 0.14 0.07 
6 Creatine** 3.91 s 0.21 0.03 0.34 0.08 
7 Creatinine** 3.08 s 0.18 0.03 0.27 0.06 
8 Betaine* 3.88 s 0.33 0.03 0.42 0.08 
9 Glucose** 3.83 m 0.32 0.03 0.45 0.09 
 Glucose * 3.66 m 0.55 0.04 0.73 0.18 
 Glucose ** 3.51 m 0.35 0.04 0.50 0.07 
10 Methionine** 3.76 m 0.50 0.05 0.81 0.21 
 Methionine** 2.14 m 0.49 0.07 0.84 0.17 
 Methionine** 2.13 s 0.43 0.06 0.75 0.16 
11 Lysine** 3.74 t 0.48 0.06 0.77 0.17 
12 Ethanol** 3.64 q 0.66 0.08 0.98 0.11 
13 Glycine** 3.52 s 0.31 0.04 0.44 0.08 
14 Taurine 3.41 t 3.11 1.41 2.28 1.96 
 Taurine * 3.18 t 0.25 0.03 0.32 0.07 
15 Hypotaurine 3.35 t 0.21 0.09 0.26 0.09 
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16 Trimethylamine –N-oxide (TMAO) 3.25 s 2.48 1.06 1.53 1.37 
17 Creatinine/Creatine** 3.01 s 4.28 1.40 0.97 0.45 
18 α-Ketoglutarate** 3.00 t 2.19 0.69 0.54 0.28 
 α-Ketoglutarate ** 2.43 t 2.52 0.75 0.85 0.36 
19 Dimethylglycine 2.93 s 1.57 0.48 1.76 1.06 
20 Trimethylamine (TMA) 2.85 s 0.21 0.13 0.23 0.06 
21 Aspartic Acid 2.84 m 0.34 0.23 0.41 0.25 
22 Citrate** 2.62 d 0.31 0.04 0.22 0.04 
 Citrate * 2.60 d 0.27 0.05 0.22 0.03 
 Citrate 2.60 d 0.30 0.03 0.44 0.21 
 Citrate 2.50 d 0.36 0.14 0.39 0.07 
23 Glutamine** 2.44 m 5.04 1.63 1.15 0.61 
24 Succinate 2.42 s 0.90 0.05 0.84 0.23 
25 Pyruvate 2.39 s 0.49 0.08 0.64 0.28 
26 Glutamate** 2.36 m 0.39 0.06 0.51 0.10 
 Glutamate ** 2.33 m 0.57 0.09 0.81 0.10 
27 Acetoacetate** 2.27 s 0.33 0.06 0.47 0.11 
28 Arginine** 1.63 m 0.31 0.06 0.45 0.06 
29 Alanine** 1.49 d 0.35 0.06 0.59 0.12 
 Alanine * 1.47 d 0.37 0.07 0.58 0.15 
30 Lactate** 1.34 d 0.54 0.06 0.93 0.13 
 Lactate * 1.32 d 0.50 0.08 0.76 0.27 
31 3-D-Hydroxybutyrate* 1.20 d 0.43 0.06 0.72 0.30 
32 Isobutyrate 1.11 d 0.15 0.04 0.18 0.05 
33 Valine** 1.04 d 0.14 0.03 0.19 0.04 
 Valine ** 0.98 d 0.14 0.03 0.20 0.04 
34 Leucine** 1.00 m 0.13 0.02 0.19 0.03 
 Leucine ** 0.94 m 0.50 0.05 0.66 0.03 
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aThe relative intensity of metabolites is expressed with their normalized peak area. Values are represented as mean ±SD (standard deviation). 
The statistics are as follows: significance difference between the control group (n=8) and treatment group (n=8) is based on two tailed student t 
test (* p<0.05, ** p<0.01). 
(E) 
Table 4.5 Metabolites identified in rat urine samples for both the control group and treatment group as measured by 1H NMR.  
(A) Pre-dose, (B) Day 1, (C) Day 2, (D) Day 3 and (E) Day 4
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Chapter 5 Conclusion and Future Work 
This dissertation mainly focused on the study of traditional Chinese medicines 
(TCMs). The results indicated that modern analytical techniques, such as CE, 
LC/MS, GC/MS, NMR, MAE and PHWE, are powerful tools for the investigation 
of natural products. 
5.1 Summary of Results 
In part I, the isolation and determination of PAs from Tussilago farfara (Kuan 
Donghua) was achieved using the proposed MAE and PHWE methods coupled 
with LC/MS. The binary mixture of CH3OH:H2O=1:1 acidified using HCl to PH 
2-3 was found to be the optimal solvent for the extraction. This might be because 
the polarity of the solvent is the most similar to those of the target compounds. For 
PHWE, the effect of extraction temperature was investigated and 60oC was 
selected as the optimal temperature. Since the physicochemical properties of 
extraction solvent could be changed at elevated temperature, the solubility of the 
target compounds could be affected. Under the optimized conditions, the MAE 
and PHWE could be completed within 15 min and 50 min, respectively. The 
coupling of the optimized extraction methods with LC/MSn allowed a rapid 
detection of both major alkaloid, senkirkine and the minor alkaloid, senecionine. 
Significant matrix-induced interferences or ion suppression in the presence of 
co-eluting peaks was not observed. The extraction efficiencies of MAE and 
PHWE were comparable to heating under reflux. All the results obtained indicated 
that the MAE and PHWE methods proposed in this work could be alternatives for 
the extraction of bioactive or marker compounds in medical plants. The methods 
coupled with LC/MSn could be used for a rapid identification of unknown 
compounds in botanical extracts with reference to a pure standard. 
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Furthermore, separation of four pyrrolizidine alkaloids (PAs), named senkirkine, 
senecionine, retrorsine and monocrotaline, was achieved using the proposed 
NACE system, and PAs contained in certain TCM were successfully detected 
using this method. With the optimized separation conditions, the four PAs were 
baseline separated in 15 min with very good repeatability. In order to improve the 
sensitivity of NACE, two simple online preconcentration methods including large 
volume sample stacking (LVSS) and field-amplified sample stacking (FASS) were 
examined. In LVSS, with the increasing of the sample injection time, the peak area 
increased. However, peak broadening always occurred when the injection time 
was too long. This can be attributed to the fact that the analytes could not be 
focused completely when the sample plug is too long. It was also found that the 
limits of detection (LODs) were increased about 5~7-fold with the optimized 
sample plug length. Since the increase of LODs was not so high in LVSS, FASS 
was investigated for further increasing of LODs. In FASS, an organic solvent plug 
was injected before sample injection to increase the sensitivity and reproducibility. 
It was found that when ACN was injected as an organic plug, the peak areas of the 
alkaloids were the highest. After the optimization of ACN plug length, sample 
injection time and sample injection voltage, the LODs were increased about 
18~89-fold for the four alkaloids. This might be because the ACN plug provided 
an empty region for sample stacking and the sample migrated very quickly in 
ACN plug and slowed down at the boundary between the organic plug and buffer 
solution. As a result, the sample was focused in the boundary. All the results 
indicate that the NACE method proposed, which is superior to routine HPLC and 
aqueous CE methods with regard to selectivity, rapidity and separation efficiency, 
is potentially an effective alternative tool for quality control and quantitative 
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analysis of herbal medicine in pharmaceutical industries. 
In part II, metabolic profiling of berberine in rat model was achieved with 
combination of GC/MS, LC/MS and NMR analysis of biofluids, such as the liver 
extracts and urine samples. The study on the body weights and histopathology 
suggested that rats could recover from the cholesterol lowering effect induced by 
berberine. Results obtained from the GC/MS analysis of liver extracts has 
revealed that the level of fatty acids, cholesterol, glucose and maltose decreased 
after the administration of berberine. The level of fatty acids, glucose and so on 
has been found increased in the urine samples with LC/MS and NMR analysis. 
The close agreement of the results from targeted data processing of LC/MS and 
the results from non-targeted data processing of 1H NMR has proved the 
reliability and accuracy of the targeted data processing method. The proposed 
approach combined with PCA provided a further insight on the metabolic changes 
caused by berberine in rats. All the results obtained in this study have proved the 
flexibility and usefulness of the approach proposed for metabonomic study. 
5.2 Limitation and Future Work 
With the work presented in this dissertation, modern analytical techniques, such as 
CE, LC/MS, GC/MS, NMR, MAE and PHWE are proved to be powerful tools for 
the natural product research. However, there still exist several aspects which 
would need to be improved in further research: 
1. MAE and PHWE were successfully applied to the extraction of bioactive or 
marker compounds in medical plants. They were friendlier to the environment 
and much simpler. However, the extraction efficiences of these methods had 
not been improved significantly for the alkaloids investigated in this 
dissertation. Further studies on how to improve extraction efficiences will be 
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valuable. For example, certain additives could be mixed with the sand together 
for PHWE. 
2. NACE was a novel CE mode developed for the analysis of natural products. It 
could show some advantages over HPLC and normal aqueous CE. However, 
the sensitivity enhancements were not so significant with the proposed LVSS 
and FASS methods for NACE. In further studies, new preconcentration 
techniques should be established. One possible method is to add some 
modifiers in the BGE for FASS, such as the ionic liquid, which could affect 
the EOF of the BGE zone. 
3. In this dissertation, the metabolic profiling of berberine in rat model was 
achieved using a combination of GC/MS, LC/MS and NMR for the analysis of 
biofluids. However, the blood biochemistry had not been investigated. It was 
found that berberine could cause the decrease of cholesterol. Further studies 
on the mechanism of the cholesterol reduction should be valuable. The rats 
could be fed with high cholesterol food first, and then berberine will be 
injected. The metabonomic studies should be able to reveal how the berberine 
affects the cholesterol levels in rats. 
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